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ABSTRACT
Genetic evidence indicating that Toll-like receptor 4 (TLR4) is the
lipopolysaccharide (LPS) receptor in mice was reported. However, biochemical
evidence that murine TLR4 confers LPS responsiveness has not been convincingly
demonstrated. Inducible cyclooxygenase (COX-2) is selectively expressed in LPSstimulated macrophages in part mediated through activation o f NFkB. Thus, we
determined whether murine TLR4 confers LPS responsiveness as evaluated by
activation of NFkB and COX-2 expression. Expression o f the constitutively active form
(ATlr4) o f TLR4 in murine macrophage cell line (RAW 264.7) is sufficient to activate
NFkB and COX-2 expression and to stimulate prostaglandin E2 synthesis. The
truncated form [ATlr4 (P712H)] o f the missense mutant Tlr4 (P712H) found in LPShyporesponsive mouse strain (C3H/HeJ) inhibits LPS-induced NFkB activation and
COX-2 expression. Inability of ATlr4 (P712H) to activate NFkB and to induce COX-2
expression is rescued by a constitutively active adaptor protein (MyD88) which
interacts directly with the cytoplasmic domain o f TLR proteins. Furthermore. MyD88
is co-immunoprecipitated with the wild type ATlr4, but not with ATlr4 (P712H) mutant.
Together, these results indicate that TLR4 confers LPS responsiveness in RAW 264.7
cells, and suggest that hyporesponsiveness o f C3H/HeJ mice to LPS is due to disruption
o f TLR4-mediated signaling pathways resulting from inability o f the mutant TLR4
(P712H) to interact with MyD88. In addition, the involvement o f Lyn, Src-protein
tyrosine kinase family, in LPS-induced signaling pathways leading to COX-2
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expression was studied. All together, the results from this study may help pave the way
to understanding the signal transduction pathways for COX-2 gene expression.
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PART 1
M URINE TOLL-LIKE RECEPTO R 4 CONFERS
LIPOPOLYSACCHARIDE RESPONSIVENESS
AS DETERM INED BY ACTIVATION OF
NF kB AND EXPRESSIO N OF THE
INDUCIBLE CYCLOOXYGENASE
1. REVIEW OF LITERATURE
1.1. Lipopolysaccharide
In the United States alone, 20,000 people die each year as a result o f septic shock
caused by Gram-negative infection (1,2,3,4). The symptom is characterized by
refractory hypotension leading to inadequate organ perfusion, multi-organ failure, and
death (5,6). The pathogenesis o f gram-negative septic shock is presumed to be due to
excess stimulation of host cells by bacterial lipopolysaccharide (LPS) endotoxin (7.8.9).
LPS is found on the outer monolayer o f the outer membrane o f most Gram-negative
bacteria so as to work like a tight shield (Fig. 1.1). It consists o f the unique molecules,
such as lipid A, core oligosaccharide, and O-specific oligosaccharide chain (Fig. 1.2)
( 10).

Lipid A is a p, 1-6 linked disaccharide o f glucosamine which is acylated with R-3hydroxymyristate at positions 2,3,2’, and 3’, and phosphorylated at positions 1 and 4 ’.
The two R-3-hydroxy-acyl groups o f nonreducing glucosamine are further esterified
with laurate and myristate. However, various molecular species o f lipid A are found in

1
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pathogenic gram negatives. This region gives rise to biological responses that LPS
induces (Fig. 1.3) (10,11).

Protein

m embrane
Lipoprotein
Periplasm

Peptidoglycan
layer

membrane

Fig.1.1. Major components o f the gram-negative bacterial envelope. The structure
of the two bacterial membranes. An endotoxin-rich outer membrane is an identifying
feature o f gram-negative bacteria. Lipopolysaccharides or LPS, are cell membrane
components o f gram-negative bacteria (e.g.. E. coli). The lipid portion o f the outer
layer o f the outer membrane is exclusively composed o f LPS molecules. A single E.
coli cell contains about 2 million LPS molecules.
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O-Antigen
O uter Core
Inner Core

O—P - 0
0

HO

HO
Lipid

Fig.1.2. Chemical structure o f the lipopolysaccharide. It consists o f a
polysaccharide, or long chain o f sugar, and lipid A. The polysaccharide, which varies
from one bacterial species to another, is composed o f the O-specific chain (O-antigen)
and the two-part core (Outer core and Inner core). Lipid A virtually includes two
glucosamine sugars modified by phosphate and a variable number o f fatty acids. It also
has negatively charged phosphate groups.
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Fig.1.3. Predominant molecular species of lipid A found in pathogenic gramnegative bacteria.
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Core region o f LPS is divided into the inner core and the outer core. The former
part is linked to the lipid and the latter is connected to the O-specific chain. The 6'
position o f lipid A is glycosylated with eight-carbon sugar, 3-deoxy-D-mannooctulosonic acid (KDO). KDO is found in most endotoxins. Thus, KDO may be a
potential target of therapy. Other core sugars include L-glycero-D-manno-heptose,
glucose, galactose, and N-acetylglucosamine (11,12). The O-specific chain typically
consists o f 20-40 repeating saccharides, but the composition is usually different from
each bacterial species. This variable region elicits production of different antibodies.
While the structure o f LPS is highly complex due to these three segments, lipid A is
sufficient to evoke the signaling events o f LPS. However, the entire lipid component of
LPS molecule is needed for optimal activity. The individual elements may combine
into a three-dimensional shape to facilitate interaction with the host cells (11,12).

1.2. LPS-induced Signaling Mechanism
Comparatively less is known about intracellular signaling events after LPS
stimulation. There is evidence to suggest that G protein (13), phospholipase C (14),
protein kinase A, and protein kinase C (15) are involved in LPS responsiveness.
However, strong evidence indicates that MAP kinases (MAPKs) signaling cascades
play critical roles in LPS signaling. Weinstein et al. first showed that within minutes o f
LPS stimulation, numerous proteins become tyrosine phosphorylated, in particular
MAP kinases p42 (ERK2), p44 (ERK1), and p38 as targets (16,17,18). The c-Jun
kinase (JNK) also becomes enzymatically activated within minutes after LPS treatment
o f macrophages (19). MAPKs require dual phosphorylation: threonine and tyrosine

5

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

residues in TXY consensus sequence must be phosphorylated to be enzymatically
activated. Dual specificity protein kinases known as a MAP Kinase Kinases
(MAPKKs) or MEKs, which are activated by upstream serine-threonine kinases,
MAPKKKs or MEKKs, catalyzes these phosphorylations (20).
Rel family members which is transcription factor, such as NF k B, have been
implicated in activation o f LPS-inducible gene expression (21). So far, it is believed
that MAPK pathway and NF k B pathway are two major signaling events by LPS
stimulation. Such signaling events lead to expression and release o f a plethora of proinflammatory marker-gene products.

1.3. Complex Formation o f LPS-LBP and CDI4
LSP itself is not intrinsically harmful. Instead, it acts by inducing myeloid and/or
nonmyeloid cells to produce a number o f proinflammtory cytokines, such as tumor
necrosis factor (TNF), interleukins, inducible nitric oxide synthase (iNOS). and COX-2,
which lead to fever, inadequate organ perfusion, multi-organ failure, and death observed
in septic shock (5.6,15,22,23, 24). During the last few decades, two major discoveries
have been reported that describe the molecular mechanisms o f LPS-induced cell
activation. The first was the discovery o f LPS binding protein (LBP). LBP is 60 KDa
glycoprotein that binds to lipid A o f LPS, resulting in LPS-LBP complex (25). The
second was the identification o f CD 14 that acts as a membrane receptor for LPS-LBP
complex. CD 14 is a 55 KDa protein o f myeloid cells. There are two types o f CD 14, a
soluble form (sCD14) and a membrane bound form (mCD14). mCD14 is a
glycosylphosphatidylinositol (GPI)-anchored membrane protein, but sCD14 lacks the

6
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GPI-anchor (26). While it was defined that mCD14 is involved in LPS activation o f
myeloid cells, such as macrophage cells, sCD14 participates in activation of
nonmyeloid cell types such as endothelial or epithelial cells that normally do not
express mCD14 (27,28). The unique feature o f CD 14 is the presence o f a leucine-rich
repeat (LRR) domain in its extracellular region (29). LPS-LBP complex binds to
mCD14 on the host cell membrane, and the current understanding is that LPS-LBP
bound mCD14 leads to activation o f LPS signaling. mCD14 however does not have
transmembrane domain to transduce LPS signaling from extracellular environment to
cytosol. Thus, it has been a puzzling question as to how mCD14 lacking a
transmembrane domain transmits the LPS signaling to a downstream cytoplasmic
pathway.

1.4. Genetic Regulation of LPS Response
Decreased sensitivity to the proinflammatory and lethal effects o f LPS were
subsequently observed in the C3H/HeJ mouse strain (30). C3H/HeJ mice were
naturally resistant to LPS preparations from Salmonella typhosa 0-901 and Escherichia
coli 0127:B8, tolerating 20 and 38 times the medial lethal dose, respectively for other
C3H sublines that are normally responsive to LPS. In addition, LPS, o r Lipid A is not
cytotoxic in vitro for macrophages from C3H/HeJ, but directly cytotoxic for those from
LPS-responsive mice (31). It was also suggested that B lymphocytes from C3H/HeJ
mice was specifically hyporesponsive to LPS, but responded normally to other B-cell
stimulators (32). LPS responses were also defective in T lymphocytes and fibroblasts
from C3H/HeJ mice (33-35). These results indicated that C3H/HeJ mice were

7
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hyporesponsive to LPS (36). Genetically, it was demonstrated that these LPS
hyporesponsive mouse strains have a defective Lps allele (Lpsd) in chromosomal
assignment o f the Lps locus on chromosome 4, while Lpsn is characteristic o f most
inbred mouse strains that are LPS responsive (37,38)
Two other LPS hyporesponsive mouse strains have been identified,
C57BL/10ScCr and its progenitor C57BL/10ScN (also known as C57BL/10ScNCr).
Coutinho et al showed that the LPS hyporesponsive phenotype o f C57BL/10ScCr was
also due to a mutation at the Lps locus, and crosses between C57BL/10ScCr (Lpsd) and
C57BL/10Sn (Lps") have yielded only the high-LPS responder phenotype, indicating
that this Lps mutation is recessive (39). In contrast. FI progeny o f crosses between
C3H/HeJ and most LPS-responder strains have intermediate responsiveness, suggesting
that this may be due to a dominant negative effect o f the C3H/HeJ Lpsd allele in vivo
(40).
Over the last three decades, the nature o f the Lps mutation has been a central
question in molecular basis o f LPS hyporesponsiveness. Using several techniques
including cDNA selection, genomic sequencing or randomly-subcloned DNA, and
comparative mapping, a candidate for Lps gene product was identified and assigned as
the Toll-like receptor 4 (Tlr4) (41,42). Based on Northern blot and RT-PCR analyses,
the LPS hyporesponsive C57BL/10ScCr and C57BL/10ScNCr mouse strains do not
transcribe Tlr4. Southern blots o f genomic DNA probed with Tlr4 identified a
chromosomal deletion involving this gene in the C57BL/10ScCr strain (an LPS
hyporesponsive subline) (42). The mouse Tlr4 gene contains one open reading frame o f

8
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2505 nucleotides, predicted to encode a protein o f 835 amino acids. This protein
consists of an extracellular domain formed by a tandem arrangement o f 22 leucine-rich
repeat motifs connected by a single transmembrane domain to an intracellular signaling
domain that shares homology with the Interleukin-1 receptor (IL-1R). Furthermore,
nucleotide sequencing o f the entire coding region o f the Tlr4 gene in endotoxin-tolerant
C3H/HeJ mice revealed a single missense mutation consisting o f a C to A transversion
at nucleotide 2135 predicting a substitution o f proline for histidine at codon 712 within
the signaling domain [Tlr4 (P712H)]. This missense mutation within the cytoplasmic
domain of Tlr4 may be a clue to explain how C3H/HeJ mice are hyporesponsive to LPS
(41). Identification o f distinct independent mutations o f the same gene in these strains
o f endotoxin-tolerant mice provided compelling evidence that Tlr4 is the gene encoded
by Lps (41,42).

1.5. Toll Superfamily (IL-1R/TLR Superfamily)
The experimental approaches to understand Toll were started by the studies on the
development of Drosophila embryo. The Toll gene was originally identified in the
Drosophila embryo as it plays a crucial role in defining the dorsal-ventral pattern
formation (43.44). Cloning and sequencing o f the Drosophila Toll gene revealed a
family o f gene with homology to Toll in mammals, plants, and insects, defined as Toll
like receptors (Tlr) as described in Fig.l .4 (45,46).
Most o f Toll gene products are type 1 transmembrane protein containing unique
structural properties, such as N-terminal leucine rich-repeat (LRR) extracellular

9
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Extracellular
region

Cytoplasmic
region

IL-1R1
IL-1RI1
IL-lRAcp
IL-lRrp

Mammals

M yD 88

hTLRl
HTLR2
hTLR3
HTLR4
hTLR5

ini

18 wheeler

Insects

dToll
Mst

(Drosophila)

DRgN
L6

Plants

M
Rpp5
Ig-like d om ain

L eucine rich repeat d om ain
T o ll/IL -lR (T IR ) dom ain

Fig. 1.4. Schematic comparison o f IL-1R/TLP superfamily protein. All members
contain a conserved cytosolic region termed the TIR domain (Toll/IL-1 R domain). IL1R subfamily contains extracellular Ig domain and TLR subfamily has the unique
extracellular domain, termed Leucine-rich repeat (LRR) domain (47).
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domain, a single-pass transmembrane domain, and a C-terminal cytoplasmic signaling
domain. The LRR is a widely dispersed m otif found in over 70 proteins o f diverse
function and origin. It has been shown that LRR domain mediates direct protein-protein
interactions, cell adhesion and signal transduction (48). But the precise function o f
LRR in the Toll gene product is unknown. The cytoplasmic signaling domain is highly
homologous to that o f the interleukin-1 receptor (IL-1R), termed the Toll/IL-1 R
homology domain (TIR domain) (49). The TIR domain is responsible for cytoplasmic
signal transduction o f Toll gene products. Due to the conserved TIR domain between
Toll gene product and IL-1R, Toll-like receptors were also named IL-1 R/TLRs.
Expressions and functions o f IL-l/TLR superfamily proteins have been studied in
insects, plants, and mammals such as human and mouse. As shown in Fig. 1.4, in
Drosophila, the Toll-family proteins have been identified: Toll, 18-wheeler (18W), Mst,
and STSDm2245 (44,50,51). When Toll was identified first, it was thought to
participate only in the establishment o f dorso-ventral polarity in the developing
Drosophila embryo (44). However another Drosophila Toll family protein, 18-wheeler,
was identified to participate in antibacterial responses in specifically adult fly by
activating the REL protein Dorsal-like immunity factor (Dif) (52).
In plants, IL-1R/TLR family proteins such as N (DRgN) (53,54), L6, M (55), and
Rpp5 (56) were identified. While these plant IL-1R/TLR superfamily proteins are not
transmembrane receptors, but cytosolic proteins, they have TIR domain and LRR
domain (53). The cellular functions o f Toll gene products in plants are also involved in
innate immunity against invading pathogen. N protein from tobacco activates an

ll

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

enhanced response in the plant during infection, which leads to necrosis o f infected
plant tissue, thereby halting pathogen growth and spread (53,54). L6 and M in flax are
required for resistance to flax rust (55). Several other plant proteins with similarity to
TLRs are involved in disease resistance, including Rpp5 in Arabidopsis (56). In
mammals, so far, ten Tlr genes were identified from human and mouse, respectively
(57,58). The mammalian Tlrs are transmembrane protein, composed o f LRR
ectodomain, transmembrane domain, and cytosolic TIR domain.
While the cytoplasmic domains and TIR domains are highly conserved between
Tlrs and IL-1 R, the ectodomains are totally different. Tlrs contain LRR ectodomain,
however all o f IL-1 R subfamily proteins have immunoglobulin (Ig) domains in their
their extracellular regions (59). Recently, it has been one o f the most intensive research
areas to elucidate what is the role o f the mammalian Tlr proteins. While their cellular
function was not well established, based on the genetic evidence resulting from the
LPS-hyporesponsive mice as mentioned above, it is believed that Tlr4 might be
involved in transducing the LPS-stimulated signaling event. Meanwhile, Yang et al.
(60) and Kirschning et al. (61) showed that human Toll-like receptor 2 (Tlr2) mediates
LPS-induced cellular signaling by in vitro transfection system with human embryonic
kidney 293 cells, as measured by activation o f N F k B or induction o f a NF k Bresponsive reporter gene. Kirschning et al also showed that human TLR4 can
constitutively activate NF kB, but fails to confer LPS-responsiveness (61). Thus, it
could be assumed that TLR2 would be a receptor for LPS. However, it was still
controversial whether TLR2 is LPS receptor or not, because the genetic evidences
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describing TLR4 is more relevant to explain the phenotype o f LPS-hyporesponsive
mice. In addition, the activation o f NF k B and expression o f certain NFxB-induced
gene products were impaired in LPS-stimulated macrophages derived from C3H/HeJ
mouse strain (62,63). Furthermore, Chow et al. identified that human Tlr4 transfection
into 293 cells induced LPS response in CD 14 dependent manner as measured by the
expression o f NFxB-luciferase reporter gene that was activated by LPS. Furthermore,
they showed that LPS antagonist. E5531, blocked Tlr4-mediated LPS response
implying Tlr4 is the LPS receptor (64). Faure et al. showed that overexpression o f the
mutant Tlr4 derived from C3H/HeJ mice in human dermal endothelial cells results in
inhibition o f LPS-induced N F k B activation (65). Thus, conclusive biochemical
evidence is still needed to show that murine Tlr4 indeed confers LPS responsiveness.

1.6. Signal Transduction of IL-1R/TLR proteins
1.6.1. M am m alian Toll-like Signaling Pathw ays
1.6.1.1. IL-1R Signaling Cascade
IL-1R/TLR proteins are ligand-stimulated receptor molecules that elicit their
pleiotropic effects through activation o f the transcription factors N F k B and AP-1. The
cytoplasmic domain o f Tlr proteins (i.e. the TIR domain) is homologous to that o f IL1R, although the extracellular Ig domain in IL -1R is quite different from the LRR
domain in Tlr. Thus, the investigation for the cellular mechanism from Tlr activation
was approached on the basis of understanding IL-1R signaling pathway.
IL-1R requires another IL-1 receptor family, IL-1 receptor accessory protein, (IL-lA cP)
to be activated. IL -1R engagement by ligand induces dimerization o f IL-1R and IL-
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1AcP (66,67). IL-1 AcP has a critical role in IL-1R activation, recruiting the
downstream signaling molecules: Toll-interacting protein (Tollip) and IL-1 receptor
associated kinase (IRAK). IL-1 AcP, not IL-1 R, directly interacts with IRAK (68,69).
Recently, Volpe et al. showed that Tollip is present in a complex with IRAK, and the
Tollip-IRAK complex is recruited to the activated receptor complex through the
association o f Tollip with IL-1 AcP. Meanwhile, Bums et al showed that an adapter
protein, myeloid differentiation factor 88 (MyD88), was co-immunoprecipitated with
the activated IL-1R in an IL-1-dependent manner. MyD88 has N-terminal death
domain (DD) that associates with another DD in IRAK and with the C-terminal TIR
domain to interact with the cytoplasmic TIR domain o f IL-IR/Toll superfamily protein
(70). Such co-recruitment o f MyD88 and Tollip-IRAK complex allows for MyD88IRAK interaction through their death domain and then triggers IRAK
autophosphorylation. In turn, the phosphorylated IRAK is dissociated from Tollip,
leading to the association with another signaling molecule for transmission of the
receptor mediated signal (71). Indeed, it has been demonstrated that using coimmunoprecipitations in IL-1 treated cells, IRAK directly interacts with TRAF6 which
is a member o f the TNF receptor-associated factor (TRAF) family. The family o f
proteins is characterized by a ring and zinc finger m otif in their N terminal and a
conserved C-terminal TRAF domain (72). Six TRAF family members, including
TRAF1, TRAF2, TRAF3, TRAF4, TRAF5, and TRAF6, have been identified and the
C-terminal TRAF domain is involved in receptor association and homo- and hetero
oligomerization o f TRAFs and serves as a docking site for other signaling proteins
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(73,74). The N-terminal zinc binding domains are involved in mediating downstream
signaling events (75,76). Green et al. showed that a dominant negative mutant form o f
TRAF 6 inhibited NFkB activation by IRAK and IL-1. Thus, TRAF 6 is a downstream
signaling molecule o f IRAK (77). Song et al. showed the association o f TRAF family
members with NFkB inducing kinase (NIK) through the conserved "WKI” motif within
the C-terminal TRAF domain (74). NIK is a novel member o f the mitogen activated
protein kinase kinase kinase family (78). It was originally identified as a TRAF2interaction protein and subsequently found to interact with all TRAF molecules, except
TRAF4 (73). The overexpression o f NIK potentially activates NFkB (73,78) and the
dominant negative mutant form o f NIK (NIK-KM) inhibited NFkB activation by TNF,
interleukin-1, CD27. human T-cell leukemia virus type 1 TAX, and Epstein-Barr virustransforming protein latent infection membrane protein 1 (73,78-82). These results
indicate that NIK participates in activating NFKB-inducing signaling cascade.
Consequently, the activated NIK activates inhibitor kB (IkB) kinase (IK K a and IKK(3)
complex and activated IKKs phosphorylate IkB, resulting in the ubiquitin mediated
degradation of IkB (83,84). IkB makes a complex with NFkB to keep NFkB
inactivated. Thus, IkB degradation leads to release the free NFkB molecule. These
events ultimately result in the translocation o f NFkB to the nucleus and the initiation o f
gene transcription. It was suggested that NIK, IKK, and IkB are part o f a large complex
o f proteins, with a molecular weight in the region o f 900 KDa, which has been termed
the signalsome (85,86). Together, IL-1 induced signaling pathway is following the
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cascade: IL-1 induced IL-lR -IL-lR A cP complex/ MyD 8 8 / IRAK/ TRAF 6 / NIK/IKK/
IkB/NFkB (Fig. 1.5).
Recently, a new molecule designated Evolutionarily-Conserved Signaling
Intermediate in Toll pathways (ECSIT) was identified. ECSIT is specific for the IL1R/TLR signaling pathways including IL-1R signaling and appears to bridge TRAF 6 to
MEKK1 by directly interacting with TRAF 6 and MEKK1 (87). MEKK1 is a 195KDa
protein that is believed to be activated upon proteolytic cleavage by a caspase into an
active 80 KDa fragment ( 8 8 ). The activation o f MEKK1 mediated by ECSIT leads to
the activation o f JNK. Together, the activation o f IL-1R/TLR signaling pathway
provides the activation o f both AP-1 and NFkB.
1.6.1.2. Toll-like Receptor 4 Signaling Cascade
The cytoplasmic domain TLR is highly similar to that o f IL-1R, and these regions
are referred to as Toll/IL-IR (TIR) domain. This TIR homology suggests that TLR
proteins may activate similar signaling pathway (57). Indeed, it has been demonstrated
that TLR signaling pathway takes advantage o f the same signaling components as IL1R signaling pathway (46). However, the involvement o f Tollip was not verified for
TLR-mediated signaling cascade, although it was shown for IL-1R signaling pathway.
While post-receptor signaling pathways share the same signaling components, the
receptor activation procedures are different between Tlr and IL -1R. LPS interacts with
LBP to give rise to LPS-LBP complex which binds to CD 14 (89).
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However, CD 14 can not transduce LPS signaling through the cell membrane, because
CD 14 does not have a transmembrane domain. Thus, it is believed that CD 14 functions
as the co-receptor for Tlr4. Indeed, Chow et al. showed that the presence o f CD 14 and
human Tlr4 induced dramatically LPS-stimulated NFkB reporter gene expression, while
human Tlr4 alone induced the reporter gene expression slightly (64). Meanwhile, in the
case o f Tlr2, Yang et al. demonstrated that CD 14 co-immunoprecipitated with Tlr2 in
the presence o f LPS. They also showed that Tlr2 forms a homocomplex through its
extracellular LRR domain o f TLR2 (90). However, it is not clear if Tlr4 also forms a
homocomplex (or heterocomplex) by LPS stimulation as Tlr2 does. Furthermore, it
remains untertain it CD 14 even interacts with Tlr4, although it is assumed that
LPS/LBP/CD14 complex interacts with Tlr4. Meanwhile, Kimoto et al. showed that
LPS response mediated through Tlr4 requires the presence o f MD2, a cell surface
protein that co-immunoprecipitated with Tlr4 (91). Chow et al. also demonstrated that
when MD2, a protein associated with the extracellular domain o f Tlr4, was expressed,
there was a marked increase in Elk-1 activity as well as ERK, JNK, and p38 MAP
kinase phosphorylation in response to LPS. They also showed that TIr4 mediated
NFkB reporter activity and IL - 8 production was enhanced by the expression o f MD2
(92). In addition, Miyake et al. showed that MD2 expression in Tlr4-expressing cells
enhanced LPS-induced NFkB activation (93). Together, these results imply that MD2
interacts with Tlr4 and with LPS stimulation. All these components form the complex
o f LPS/LBP/CD14/MD2/Tlr4, as described in Fig.1.6.
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1.6.2. Drosophila Toll Signaling Pathw ay
On Drosophila Toll, recent studies revealed the striking similarities between
Drosophila Toll signaling pathway and mammalian Tlr signaling pathway (Fig. 1.5).
The current model o f Toll signaling pathway proposes that this receptor is activated by
ligand-dependent receptor dimerization, induced by an endogenous peptide ligand,
Spatzle, which is proteolytically activated by the protease, Easter (94,95). The activated
Toll recruits the adapter protein, Tube, and the serine-threonine kinase, Pelle. Tube and
Pelle are homologous to M yD 8 8 and IRAK, respectively, in mammalian Tlr signaling
cascade (Fig. 1.5) (96). Pelle interacts with an additional downstream molecule, the
Drosophila TRAF 6 (dTRAF 6 ). The activated dTRA F 6 results in the activation of the
Drosophila IKK, Drosophila LPS-Activated Kinase (DLAK), which phosphorylates
Drosophila IkB, called Cactus. Like the role o f IkB in mammals, Cactus interacts with
Drosophila NFkB like proteins. Dorsal and dorsal-like immunity factor (Dif) to keep
them inactivated. Consequently, the activation o f Cactus by DLAK releases Dorsal or
Dif. The free Dorsal or D if translocates to the nucleus where they induce gene
transcription (97). Recently, Kopp et al. identified Drosophila ECSIT (dECSIT) which
interacts with dTRAF 6 as in mammal (87). Thus, it is clear that Drosophila Toll
signaling pathway is similar to the mammalian Tlr signaling cascade both in terms o f
structure and function.
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1.7. Innate Immunity: Biological Significance of IL-l/TLR
Superfamily
The significance o f Toll gene products has been underscored because they are
involved in innate immunity. In the Drosophila embryo. Toll participates in dorsalventral development, but in adult flies, Toll induces the antifungal peptide, drosomycin,
which is mediated through the activation o f Dorsal (98). In comparison with Toll, 18wheeler causes the expression o f the anti-bacterial peptide, attacin, through the
activation o f Dif. While Dorsal and D if are Drosophila NFkB proteins. Dorsal is
selectively activated by Toll and D if is specifically activated by 18-wheeler (98,99).
Several cytoplasmic plant disease-resistance genes with sequence homology to
members o f Tlr family have also been cloned and shown to mediate host defense
against specific viral and fungal plant pathogens as previously mentioned (54,100). So
far, 400 peptides have been reported to participate in innate immunity, not only of
insects, but also of all multicellular organisms that were investigated, including human
and plants. Among these peptide, Defensins are representative. Defensins have wide
spectra o f activity directed against various bacteria, fungi, and enveloped viruses
(101,102). Although the molecular mechanisms are not fully understood, they may
involve the transient appearance o f channel-like structures. Defensins and most other
antimicrobial peptides act by permeabilizing the cell membranes o f microorganisms,
resulting in the efflux o f solutes (103). As in Drosophila, antimicrobial peptides also
counter infection in mammals (102,103). a-D efensins are major constituents o f the
microbicidal granules o f blood granulocytes and are also abundantly expressed in
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intestinal epithelial cells specialized for host defense functions. A constitutively
expressed human epithelial P-defensin is abundant in the kidney and the urogenital
tract, and an infection- or cytokine-inducible P-defensin is abundant in the skin. In
addition to defensins, mammals produce cathelicidins which is a group o f myeloid
antimicrobial peptides (102,104). In addition, the complement cascade is one o f the
major roles in mammalian innate immunity. It is activated either directly or indirectly
by microorganisms and leads to the phagocytosis through opsonization or the assembly
o f a pore-forming membrane attack complex on the surface o f microorganism (105).
The innate immune system that is an earlier evolutionary form o f host defense
serves the second function, such as stimulating and orienting the primary adaptive
immune response by controlling the expression o f co-stimulatory molecules. Indeed,
mammalian Tlr activation leads to expression and release o f a plethora o f cytokines,
such as interleukins. These cytokines play direct or indirect role in adaptive immune
system. Based on recent data on Tlr protein, it is suggested that Tlr4 is involved in
LPS-induced signaling pathway. In contrast to TIr4, it was suggested that Tlr2 is the
receptor for bacterial lipoprotein (106). Recently, Hemmi et al. demonstrated that
TLR9 is activated by bacterial CpG dinucleotide (58). Such cellular function o f Tlr
proteins implies that Tlr protein works as the tollgates for pathogen selection.
It is clear that disruptions in innate immunity predispose human to infection as
described in the following examples. In the severely burned patient, the disruption o f
skin as not merely a barrier, but an organ adorned with antimicrobial peptides and firstline effecter cells like macrophages, poses great risks to infection. In patients with
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cystic fibrosis, the alterations in salinity o f the bronchial airway fluid appear to disable
the function o f antimicrobial peptides that are found in the respiratory epithelium,
thereby leading to colonization and infection with organisms like Staphyloccoci and
Pseudomonas (107,108). As Toll-LBP-CD14 pathway was elucidated, new targets that
modify these pathways may prove effective in designing drugs for the treatment o f
septic shock. Finally, the ability to produce large amounts o f both insect and
mammalian antimicrobial peptides may provide new classes o f antibiotics.

1.8. Eicosanoid
‘Eidosanoid’ is a term to describe compounds derived from C 20 fatty acids and the
term is now generally used to identify the paracrine hormones derived from free
arachidonic acid (109). The eicosanoids are divided into two major groups. One is the
leukotrienes that are formed by the initial conversion o f free arachidonate to leukotriene
(LTA 4 ) by the enzyme 5’-lipoxygenase. Subsequent metabolism o f LTA 4 to a variety
of other bioactive compounds (e.g. LTB 4, LTC 4) is determined by the presence or
absence o f enzymes that further metabolize LTA4 and its products (Fig. 1.7). The other
is the prostnoids that are formed by the initial conversion o f arachidonate to a common
intermediate, PGH 2, by the enzyme prostaglandin H synthase (PGHS). Prostaglandin
synthase is able to carry out two distinct, sequential biochemical reactions. The
cyclooxygenase activity o f PGHS converts free arachidonic acid to prostaglandin G 2
(PGG 2) that is then converted to PGH 2 by the hydroperoxidase activity o f PGHS.
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PGH? is the common precursor for all the prostanoids. The subsequent synthesis o f the
prostanoids, such as the prostaglandins (PGs), thromboxanes, and prostacyclins, in
various tissues and cells is determined by the presence o f the biosynthetic enzymes that
convert PGHi to the various prostanoids. PGs play a role for normal physiology
including motility, vascular tone, angiogenesis, mucosal protection, and immune
responsiveness (110). PGs are also important mediators o f inflammation.
Thromboxanes mediate a platelet aggregation, while prostacyclin (PGIi) produced in
endothelial cells inhibits a platelet aggregation (111, 265). PGs are synthesized and
secreted by a wide variety o f cells only when stimulated by a multitude o f cell
perturbations, ranging from mechanical to chemical stimuli. Once released, PGs act as
autocrine or paracrine factors to regulate the functions o f various differentiated cells.
The ubiquitous presence o f PG-metabolizing enzymes makes these mediators unstable
and their actions short-lived. Due to the short half-lives o f PGs in general, the levels and
activities o f PG synthetic enzymes determine the bioactivities o f PGs within tissues
(112,113).
In arthritis, PGs contribute to synovial inflammation by increasing local blood
flow and potentiating the effects o f mediators such as bradykinin and interleukin (IL)-l
that induce increases in vasopermeability (114). PGs also may induce osteoclastic bone
resorption, suggesting a mechanism through which they may contribute to joint erosion
(115). In patients with inflammatory joint disease, there is an increase in synovial and
cartilage PGHS activity (116).
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1.9. Cyclooxygenase (COX)
Prostaglandin H synthase (PGHS) or Cyclooxygenase (COX) is the key enzyme
that catalyzes the conversion o f arachidonic acid and other eicosanoids. COX has two
distinct enzyme activities: a cyclooxygenase activity to catalyze the conversion o f
arachidonic acid to PGG 2 , and a peroxidase activity to catalyzes the conversion o f PGG?
to PGHi. Consequently, PGH 2 is converted to PGD 2, PGE 2, PGF 2Q, PGI2, or
thromboxane A2 (TXA 2) by distinct synthases. In addition, several results showed that
the cyclooxygenase and peroxidase sites are physically and functionally separate within
the enzyme (117-119). Mizuno et al demonstrated that non-steroidal anti-inflammatory
drugs (NSAIDs) compete directly with arachidonate for binding to the cyclooxygenase
site and inhibit cyclooxygenase activity, but have no effect on peroxidase activity ( 1 2 0 ).
Two isoforms o f the enzyme have been characterized: a constitutive C O X -1 and a
mitogen-inducible COX-2 (121-123). At the deduced amino acid level, the COX-1 and
COX-2 polypeptides are 61% identical (119, 124). Two N-terminal N-linked
glycosylation sites, the axial and distal heme-ligating histidines, active-site tyrosine, and
aspirin-modified serine are conserved. In addition, both polypeptides end with the
sequence STEL. as sequence that is reminiscent o f the endoplasmic reticulum retention
sequence KDEL. The 3’-untranslated region (UTR) o f the COX-2 transcripts is
estimated to be 2.5 kb in size. The human COX-2 mRNA contains at least 12 copies o f
the AUUUA, "Shaw-Kamen” m otif that is implicated in the rapid degradation o f many
cytokine and oncogene mRNAs (125). The COX-1 protein contains a 17 amino acid
sequence near its amino terminus that is not present in the inducible COX-2 protein
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(126). In contrast, COX-2 contains an 18 amino acid sequence near its carboxyl
terminus that is not present in the COX-1 molecule and a putative N-linked
glycosylation site is found at the C- terminal unique 18 amino acids (Fig. 1.7). The
presence of this 18 amino acid epitope has been used to prepare antibodies that can
distinguish the COX-2 protein from the COX-1 protein in immunoblot assay (127).
COX-1 is the constitutive form o f the enzyme and ubiquitously expressed in most
cells. It provides certain homeostatic functions, such as maintaining normal gastric
mucosa and aiding in blood clotting by abetting platelet aggregation (128). COX-2 is
the inducible form and expressed in response to inflammatory and other physiologic
stimuli, growth factors, tumor promoters, hormones, bacterial endotoxins, and cytokines
(129-132). Although both COX-1 and COX-2 convert arachidonic acid to
prostaglandins, there are many differences between the COX isoforms. One major
distinction is that COX-2 is the principal isoform that participates in inflammation
(133). O f the two isoforms, the inducible COX-2 enzyme is thought to make the more
important contribution to synthesis o f PGs at sites o f inflammation as suggested by
studies o f cultured inflammatory cell ( 2 2 ) or o f synoviocytes from rheumatoid arthritis
and osteoarthritis patients (134). COX-2 expression is inhibited by glucocorticoids
such as dexamethasone at the level o f transcription and translation, while these agents
have little effect on the expression o f C O X -1 (135,136,289). COX-1 is also not
upregulated by inflammatory or other stimuli. It leads to a steady state level o f COX-1
responsible for the production o f basal levels o f PGs (137). Together, those results
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Fig. 1.8. Schem atic com parison o f COX-1 and CO X-2 proteins. A constitutive
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oncogene mRNAs. The constitutive CO X-1 protein contains a 17 amino acid sequence
near its amino terminus that is not present in COX-2 protein. In contrast, COX-2
contains an 18 amino acid sequence near its carboxyl terminus that is not present in the
COX-1 molecule. The presence o f this 18 amino acid epitope has been used to prepare
antibodies that can distinguish the COX-2 protein from the COX-1 protein.
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suggest that COX-2 is responsible for production o f prostaglandins involved in
inflammation.
Another distinction between COX-1 and COX-2 involves their differential
expression. The two isoforms are encoded by genes located on separate chromosomes.
COX-1 is located on human chromosome 9, while COX-2 is on human chromosome 1
(131,138). Similarly, in the case o f mouse, COX-1 and COX-2 genes map to distinct
chromosomes (Ch. 2 and Ch. 1, respectively). The C O X -1 and COX-2 genes are
similar in structure. The COX-2 gene contains ten exons and nine introns, but the exon
encoding the hydrophobic 17 amino acid sequence in COX-1 is missing in the COX-2
gene. However, the COX-2 gene is substantially smaller that the C O X -1 gene; COX-2
gene is approximately

8

kb, while the COX-1 gene is about 25 kb (139, 140).

COX-1 gene is a developmentally regulated “ housekeeping” gene and lacks a
TATA box. While it is not well known about the details o f the regulation o f COX-1
gene expression, COX-2 gene is characterized as an immediate-early gene (141). While
Ristimaki et al suggested that post-transcriptional regulation contributes to the
magnitude and duration o f COX-2 mRNA expression in other systems (142), the e x 
acting elements in 5’-flanking region o f COX-2 gene are crucial for modulating COX-2
gene expression. The transcriptional activation o f the COX-2 gene appears to be the
major mechanism for increasing COX-2 expression. The COX-2 promoter contains a
TATA box. Several relevant enhancer sequences, such as CRE, NFkB, NF-IL 6 , E-box,
AP-2, SP-1, have been identified in the human and murine COX-2 gene promoter as
shown in Fig. 1.9 (143,144). In case o f murine COX-2 promoter, there are sequences
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Fig. 1.9. Organization o f the putative cis-acting elements in the 5 ’-flanking region
o f the COX-2 gene from mouse and human.
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that match binding sites for SP-1 and NF-IL 6 within the first 370 bp. Between
nucleotides -56 and -48, there are overlapping ‘CRE’ and ‘E-Box’ sequences (Fig. 1.9).
The CRE sequence is associated with binding o f transcription factors o f the ATF family
(CREB, ATF-2, ATF-3, etc), while the E-box is associated with the binding o f members
o f the Myc, Max, MyoD, and USF transcription factor family. In bovine endothelial
cells, a NF-1L6 (CEBPP) site is responsible for induction o f COX-2 by
lipopolysaccharide and tumor-promoting phorbol ester while the same site is
responsible for tumor necrosis factor a-m ediated induction o f COX-2 in MC3T3-E1
cells (145,146). An E-box sequence is essential for basal transcription and for
luteinizing hormone- and gonadotrophin-releasing hormone stimulated transcription
(147). A cAMP response element (CRE) mediates the effect o f SRC protein on COX-2
expression in fibroblasts (148). COX-2 expression can be induced through multiple
signaling pathways involving protein kinases A and C, tyrosine kinases, phosphatases,
bacterial endotoxin (LPS), and Src. The crucial signaling pathway for COX-2 gene
expression appears to be dependent on the cell type and stimulants (108,130,149). In
addition, two putative NF k B binding elements were found in both human and mouse
COX-2 promoters (Fig. 1.9 and 1.10). Recently, the requirement o f NF k B binding
element for COX-2 expression is controversial.
Prostanoid production by COX-i and COX-2 appears to be initiated through
distinct signaling pathways that may rely on the activation o f different phospholipases
(122). W hile COX-1 is found in equivalent concentrations in both the nuclear envelope
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Fig.1.10. Putative NF kB binding elements in the S’-flanking region of COX-2 gene.
Tow NF k B binding elements were found in human and mouse COX-2 promoter. The
consensus sequence o f NF k B binding site is 5’-GGGRNNYYCC-3\ where R is A or G,
Y is T or C, and N is any nucleotide (150, 151).
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and the endoplasmic reticulum membrane, the concentration o f COX-2 within the
nuclear envelope is approximately twice the concentration in the endoplasmic reticulum
membrane. In addition, products o f COX-2, but not COX-1, is localized to the nucleus,
which suggests that COX-2 may independently signal to the nucleus (152). Although
COX-2 is usually not detectable during normal physiologic conditions, Cryer et al.
reported reported that there is also some constitutive expression o f this isoform in the
rat kidney and brain, human prostate and lung, bone, and female reproductive system
(267). COX-2 expression also occurs in transformed or cancerous cells. The first
COX-2 cDNA was initially characterized on the basis o f its elevated expression in Rous
sarcoma virus transformed chicken embryo fibroblasts (153). Furthermore, Eberhart et
al. and Kargman et al. showed that the constitutive overexpression o f COX-2 has been
detected in colon carcinomas (154,155). The two major substrates for both COX-1 and
COX-2 are arachidonic acid and dihomo-y-linolenic acid. They are also capable o f
catalyzing the oxygenation o f eicosapentaenoic acid (EPA), y-linolenic acid, a-linolenic
acid, and linoleic acid (156,157). EPA is converted to PGH 2, whereas the 18-carbon
fatty acids are converted to monohydroxy acids. There are subtle differences in
substrate specificities between COX-1 and COX-2. In general, 18-carbon
polyunsaturated fatty acids are more efficiently oxygenated by COX-2 than by COX-1.
Docosahexaenoic acid (DHA, 22:6n-3) is a competitive inhibitor o f both COX-1 and
COX-2 without being a substrate for either enzyme (158).
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1.10. The Signaling Pathways Leading to COX-2 Gene
Expression
While the expression o f COX1 is generally constitutive in most cells, COX-2 is
rapidly and transiently induced by a variety o f factors, such as cytokines, hormones, and
tumor promoters, which activate various signaling pathways. Among various signaling
pathways, G protein-mediated pathways, as well as the protein kinase C (PKC)mediated pathway activated by phorbol 12-myristate 13-acetate (PMA) and the tyrosine
kinase-mediated pathways activated by both growth factor receptors and Src kinase, can
stimulate the expression of COX-2 gene (159,294,295). The 5'-flanking region of
COX-2 was identified from human (160) and mouse (161). Regardless o f the species,
the common cis acting elements in COX-2 promoter region are canonical TATA box,
CRE, NF-IL 6 (C/EBPP), AP2, SP I, NFkB, and GATA boxes. Various transacting
elements should be activated via phosphorylation by a variety o f signaling pathways so
that those cis acting elements enhance the transcription o f COX-2 gene. Therefore, it is
quite important to understand various signaling pathways leading to activation o f
transcription factors for COX-2 gene expression. However, the signaling pathways
leading to COX-2 gene expression depend on different cell types. But, several wellestablished signaling pathways for COX-2 gene expression were suggested, as
described in Fig. 1.11.
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Fig.1.11. The comprehensive signaling pathways leading to COX-2 gene
expression. LPS induces not only NFkB activation, but also MAP kinases including
ERK1/2, JNK, and p38. While TLR4 activation leads to activation o f NFkB and JNK,
it is not clear if the activated TLR4 induces ERK1/2 and p38. v-Src leads to the
activation o f Raf and MEKK1 and then activates ERKs and JNK, respectively. TF,
transcription factor. ERK, extracellular-signal-regulated kinase; MEK, mitogenactivated protein kinase kinase (MAPKK); MEKK, mitogen-activated protein kinase
kinase kinase (MAPKKK); JNK, c-Jun N-terminal kinase; JNKK, JNK kinase; PPAR,
peroxisome-proliferator activated receptor; RXR, retinoid X receptor; PUFA, poly
unsaturated fatty acid; TF, transcription factor; PGs, prostaglandins.
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First, it was reported that v-Src induces COX-2 gene expression in fibroblasts by
the activation o f JNK leading to activation o f transcription factor, c-Jun, which binds to
CRE site in COX-2 promoter (148,162). v-Src is a constitutively active form o f c-Src
kinase, and activates JNK by phosphorylation at serines 63 and 73. Xie et al.
demonstrated that v-Src-induced COX-2 gene expression is mediated by Ras (162).
There are several Ras effector proteins, such as Raf, PI3K, or MEKK, leading to
phophorylation o f transcription factors (163). Among these effector proteins is MEKK
that is downstream o f Ras and activates JNK leading to phosphorylation o f c-Jun (164).
In tum, phosphorylated c-Jun can form heterodimers with c-Fos to bind to CRE
sequence in COX-2 promoter (165). Therefore, it was suggested that vSrc/Ras/MEKK/JNKK/JNK signaling pathway participates in v-Src-induced COX-2
gene expression. Indeed, it was demonstrated that a dominant negative JNK attenuated
the v-Src-induced COX-2 promoter luciferase activity, but overexpression of wild-type
JNK1 potentiates v-Src-medicated COX-2 promoter luciferase activity (148).
Additionally, v-Src also activates another MAP kinase enzymes, ERK-1 and ERK-2, via
R af kinase (166). Indeed, co-expression o f ERK-1 or ERK-2 potentiates v-Src-induced
COX-2 promoter activity and co-expression o f dominant negative ERK-1 or ERK-2
substantially attenuate v-Src-induced COX-2 promoter activity. Moreover, a dominantnegative Raf-1 suppressed v-Src-mediated COX-2 promoter activity. Therefore, the vSrc/Ras/Raf/MEK/ERK pathway plays a role in v-Src-induced COX-2 gene expression
(148). However, contrary to JNK that phosphorylates c-Jun, ERKs phosphorylate and
activate TCF/Elk-1 that is responsible for increased expression from the c-Fos gene
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(167,168). Thus, v-Src/Ras/Raf/MEK/ERK pathway may increase c-Fos and c-Jun
protein abundance as a secondary response, and in turn, the activated c-Fos and c-Jun
by v-Src/Ras/MEKK/JNKK/JNK pathway bind to CRE element to enhance COX-2
gene expression. Xie et al also showed that platelet-derived growth factor (PDGF) or
serum strongly induces COX-2 gene expression and its receptor occupancy by such
ligand is connected to Ras/MEKK/JNKK/JNK and Ras/Raf/MEK/ERK signaling
pathways leading to the elevated COX-2 gene expression in fibroblast (169).
Second, Meade et al. demonstrated recently that fatty acids can induce COX-2
gene expression mediated though peroxisome proliferator activated receptors (PPARs)
in epithelial cells and a putative PPAR response element (PPRE) was identified on
COX-2 promoter (170). PPARs are members o f the nuclear hormone receptor
superfamily which regulate gene expression by binding to a recognition sequence
termed PPRE and to date, three subtypes o f PPAR ( a , p/8 , and y) have been identified
(171). Transcriptional regulation by PPARs is achieved through PPAR-RXR (where
RXR is the receptor for 9-cis retinoic acid) heterodimers (172). Fatty acids are ligands
for PPARs, which implies that fatty acids are potential modulators for gene expression,
such as COX-2, mediated through PPARs.
Third, LPS or endotoxin triggers very intricate signaling pathways leading to
COX-2 gene expression as well as other cytokines in macrophage cells (173). One o f
LPS-induced signaling pathways is the mitogen-activated protein kinase (MAPK)
pathway mediated through Ras protein. One potential effect o f cells with LPS
contamination is an activation of protein tyrosine kinase (PTK), such as Src family
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proteins, although the precise mechanism has not been elucidated. Moreover LPS
induced expression o f proinflammatory cytokines was inhibited by various PTK.
inhibitors (174-177), and LPS treatment leads to the elevated expression o f Lyn, Fgr,
and Hck proteins. Furthermore, the Src tyrosine kinase family member, Lyn, was found
to be activated and associated with LPS co-receptor, CD 14 after LPS treatment (178).
Therefore, LPS triggers the activation o f Src-family kinases. It was shown that Ras is
able to activate Raf-1 in macrophage cells (179). Additionally, Geppert et al.
demonstrated that the dominant negative mutants o f both Ras and Raf-1 suppressed
LPS-induced activation o f TNF promoter, although a constitutively active Raf-1 could
not induce TNF promoter activity without LPS stimulation in macrophage cells,
RAW264.7 (180). Indeed, LPS rapidly phosphorylates and activates Raf-1 and
activated Raf/MEK/MAP-kinase (ERKs) pathway was inhibited by genistein, a tyrosine
kinase inhibitor in macrophage cells, BAC-1.2F5 (181). Thus those results imply that
Raf-1 must lie downstream o f tyrosine kinase to constitute PTK/Ras/Raf/MEK/MAPK
(ERK1/2) signal transduction pathway by LPS stimulation in macrophages.
However, such signaling pathway by LPS action may be challenged by several
reports. First o f all, the same pathway is activated by the growth factor CSF-I (182)
and by T N F-a (270,271). In addition, Lowell et al showed that Hck, Fgr, and Lyn are
not obligatory for LPS-initiated signal transduction by using hck' ' fgr'7' lyn'7' triple
mutant mice (185). Their analyses indicated that both elicited peritoneal (PEM s) and
bone marrow-derived macrophages (BMDMs) from the triple mutant mice have no
major defects in LPS-induced activation, although the total protein phosphotyrosine

38

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

level is greatly reduced in macrophages derived from the same mutant mice. They also
showed that the activation o f ERK1/2 is the same in normal and mutant macrophages
after LPS stimulation. These data suggest that these Src-related kinases may not be
absolutely required for LPS-induced macrophage activation. However, an important
role for these kinases in LPS-mediated signal transduction can not be excluded in
normal macrophages.
LPS receptor, Tlr4, was identified and a signaling pathway induced by LPS was
established. LPS binds the soluble LPS binding protein (LBP) and the complex binds
CD14, a monocyte/macrophage receptor molecule that is expressed in both soluble and
membrane-associated forms. CD 14 presents the LPS-LBP complex to the LPS
receptor, Tlr4, a member of the Toll/IL-IR family proteins, which has T1R domain at
cytoplasmic C-terminal end. The TIR domain o f activated Tlr4 recruits an adaptor
molecule, MyD 8 8 , which has DD domain at N-terminal end and TIR domain at Cterminal end. The TIR domains make a noncovalent interaction between Tlr4 and
MyD 8 8 molecules. In turn, another downstream signaling molecule IRAK, through DD
domain interaction between MyD 8 8 and IRAK, needs to be recruited to MyD 8 8 bound
to Tlr4 cytoplasmic domain. Recently, it was identified that IRAK is present in a
complex with another adapter molecule in the absence o f stimuli. Upon IL-1R
activation, it was shown that Tollip-IRAK complex is recruited to IL-1 AcP, not to IL1R to transduce a signaling. While it still needs to identify that Tollip-IRAK complex
participates in LPS-induced and Tlr4-mediated signaling pathway, IRAK interacts with
MyD 8 8 through their death domain and then IRAK autophosphorylation is triggered. In
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turn, the phosphorylated IRAK is dissociated from Tollip, leading to the association
with TRAF 6 for transducing the receptor mediated signal. TRAF 6 is able to activate
NIK and then leads to the activation of IKKs and consequently activation o f NFtcB
through ItcB degradation. O ’Connell et al showed that the activation o f IKK2 (IKKP),
not IKK1 (IKKa), is required for the LPS-induction o f NFkB dependent gene
expression (186). Recently, new adapter molecule, ECSIT, for TRAF 6 was identified
and appears to bridge TRAF 6 to the MAP kinase MEKK1 by directly interacting with
TRAF 6 and MEKK1 (87). MEKK1 is a 195KDa protein that is believed to be activated
upon proteolytic cleavage by a caspase into an active 80 KDa fragment ( 8 8 ). The
activation o f MEKK1 mediated by ECSIT leads to the activation o f one o f MAP
kinases, JNK, which phosphorylates transcription factor, c-Jun. Therefore, the LPSactivated TLR4 signaling pathway provides the activation o f both JNK and NFkB.
Besides activating ERKs and JNK. LPS also phosphorylates and activates another
MAP kinase, p38, in RAW264.7 cells (173,180,187,188), although the mechanism for
activating p38 is not elucidated to date. Meanwhile, several studies revealed that the
overexpression o f protooncogene Tpl2 that encodes a serine threonine protein kinase
activates the ERK. JNK, and p38. as well as NFAT and NF-kB in a variety o f cell types
(189-191), as LPS activates the same pathways (173). Recently, Dumitru et al
determined the MAP kinase activation with Tpl2-/~ and Tpl2+/+ mice before and after
stimulation with LPS. According to their results, the inactivation o f Tpl2 specifically
inhibited the activation o f ERK 1 and ERK2 upon LPS stimulation. Therefore, it
implies that Tpl2 is required to activate ERK1 and ERK2 MAP kinases by LPS (192).
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However, it should be still investigated how Tpl2 functions to result in activation o f
MAP kinase. Meanwhile, Yang et al showed the increased ERKs, JNK, and p38 MAP
kinase phosphorylation in response to LPS, when human TLR4 and MD-2 were co
expressed in HEK293 cells (92).
As described above. Three major signaling pathways participating in COX-2 gene
expression. In nuclear level, c-Jun by MAP kinase pathway, PPAR as a nuclear
hormone receptor, and NFkB by TLR4 mediated pathway are three major transcription
factors for COX-2 gene expression. The 5’ flanking region o f COX-2 has various cis
acting transcriptional elements including CRE, PPRE, NF-IL 6 , and NFkB binding
elements. Herschman et al suggested that among these cis-acting elements, CRE and
NF-IL 6 are required for the optimal expression of COX-2 and NFkB may not be
required for efficient COX-2 reporter transcription upon LPS stimulation (193).
Meanwhile, Mestre et al suggested that NFkB, NF-IL 6 , and CER sites mediate COX-2
gene expression independently in response to LPS treatment and each cis acting element
alone was less effective than the intact promoter in mediating COX-2 gene expression.
Therefore, they suggested that there is redundancy between cis acting elements on
COX-2 promoter region (194). However, our study strongly demonstrated that NFkB
activation alone is sufficient and required for COX-2 gene expression by LPS (195).

41

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

2 INTRODUCTION
The pathogenesis of gram-negative septic shock is due to excess stimulation o f
host cells by bacterial lipopolysaccharide (LPS) endotoxin (1,2,12). Such stimulation
leads to expression and release o f a plethora o f pro-inflammatory marker-gene products
and lipid mediators, which in turn can initiate a chain of events leading to systemic
toxicity (3,4). However, initial recognition o f LPS by cells o f the immune system is
required to defend the host from a gram-negative infection before it becomes widely
disseminated (5,6).
Identifying the downstream signaling pathways derived from LPS stimulation is
o f fundamental importance to understanding the cellular mechanism of gram-negative
septic shock. Previously, CD14, a glycosylphosphatidyl inositol (GPI)-linked
membrane protein widely expressed in mononuclear cells, is considered a high-affmity
receptor for LPS (26,27,28). However, CD 14 lacks a cytoplasmic domain. Thus, there
has been a puzzling question as to how CD 14 transmits extra-cellular signals into
downstream cytoplasmic signaling pathways. Recently, it was demonstrated that
human toll-like receptor 2 (TLR2) mediates LPS-induced cellular signaling (60,61).
Human TLR4 can constitutively activate NF k B, but fails to confer LPS-responsiveness
(60). The human Toll protein is a trans-membrane protein with an extra-cellular
domain consisting o f leucine-rich repeats (LRR), and a cytoplasmic domain
homologous to that o f IL-1 receptor (198).
Genetic evidence indicating that murine TLR4 is the LPS receptor was
demonstrated using two mouse strains [C3H/HeJ and C57BL/10ScCr including its
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progenitor C57BL/10ScN (also known as C57BL/IOScNCr)] which are hyporesponsive
to LPS (40,41,42). The C3H/HeJ strain has Tlr4 with a missense mutation to replace
proline with histidine at position 712, whereas the C57BL/10ScCr strain is homozygous
for a null mutation o f Tlr4. It was also demonstrated that activation of NF k B and
expression o f certain NFKB-induced gene products in LPS-stimulated macrophages
derived from the C3H/HeJ mouse strain were impaired (62,63). In addition,
overexpression o f the mutant Tlr4 derived from C3H/HeJ mice in human dermal
endothelial cells results in the inhibition o f LPS-induced NF k B activation (65). Arbour
et al showed that the missense mutations (Asp299Gly and Thr399Ile) in extracellular
domain o f human Tlr4 causes a blunted response to LPS in humans (196). However,
biochemical evidence that murine Tlr4 indeed confers LPS responsiveness has not been
conclusively demonstrated. Thus, the first aim o f our research is to demonstrate
whether Tlr4 mediates LPS-induced signaling in murine macrophage RAW264.7 cells.
Activation o f Toll proteins and 1L-1 receptor induces the recruitment o f the
adapter molecule, MyD88 (49,67,70), and IRAK. The activation o f IRAK by
autophosphorylation results in an interaction with TRAF6 followed by the activation o f
NIK and IKKs, which in turn leads to the activation of NF k B and expression o f NFKBinduced gene products (72,73,77). Results from our previous studies indicate that LPS
induces the selective expression o f the mitogen-induced cyclooxygenase (COX-2) in
murine macrophages (22,175) and LPS activates N F kB in macrophages (24). Thus, it
has been assumed that LPS-induced COX-2 gene expression would be mediated
through the N F k B pathway. Recently Wadleigh et al suggested that the CRE and the
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NF-IL6 cis acting elements, but not the E-box or the putative NFkB site (Fig. 1.9), in the
murine COX-2 promoter are important for efficient COX-2 transcriptional induction by
LPS in murine macrophages, RAW264.7 (193). Their results contradicted our previous
report regarding the role o f NFkB in LPS-induced COX-2 expression in macrophages
(24). Therefore, the role o f NFkB in LPS-induced COX-2 expression in macrophages
is not clearly established. The second aim o f this research is to demonstrate whether the
activation o f NFkB is required and sufficient to induce COX-2 gene expression.
Because the COX-2 gene is over-expressed in sites o f inflammation and tissues o f many
types o f tumors (33,134,153-155), elucidating the signaling pathways is the key to
understanding why COX-2 is over-expressed in such pathological states and can
provide crucial information for identifying the potential targets for pharmacological and
dietary modulation. In addition, while the genetic evidences were established that the
null mutation and missense mutation o f Lps locus causes the LPS-hyporesponsive mice.
C3H/HeJ and C 57Bl/10ScCr (40-42), biochemically, it was not elucidated why such
mutations result in the LPS-hyporesponsiveness phenotype. Our third goal is to
determine how Tlr4 mutation impairs LPS-induced responses.
While Tlr4 and IL-1R elicits pleiotropic effects through activation o f transcription
factors, NF k B and AP-1 by activating JNK, it was already identified that LPS induces
the activation o f phosphotyrosine kinases and MAPKs including ERK1/ERK2, p38, and
JNK. However, based on the current results on Tlr4 that mediate LPS-stimulating
signaling, it is unable to elucidate how these kinases could be activated through the
activation o f Tlr4. It implies that there may be other signaling molecules for
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transmitting LPS-induced signaling to the activation o f PTKs or MAPKs through Tlr4.
Thus the fourth aim o f our research is to identify the molecules that are involved in the
Tlr4 signaling pathway for the activation o f MAPKs or PTKs.
We have addressed in this study three important issues in elucidating LPSstimulated signaling pathways in murine macrophages. First, we determined whether
the activation o f N F k B is sufficient and required for LPS-induced COX-2 expression
and second, we determined whether the activation o f Tlr4 confers LPS-responsiveness
as evaluated by the activation o f N F k B and the expression o f COX-2. Third, we
determined why the Tlr4 mutant with a missense mutation at position 712 fails to
transmit the LPS-induced signal to downstream signaling pathways.
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3. M ATERIALS AND M ETHODS
3.1 Reagents
Lipopolysaccharide (LPS) was purchased from DIFCO (Detroit, Michigan). Flag
antibody M2 was purchased from Sigma (St Louis, MO) and HA antibody 12CA5 was
from Roche (Indianapolis, IN). Goat anti-mouse immunoglobulin G (IgG) antibodies
conjugated to horseradish peroxidase were purchased from Amersham Pharmacia
Biotech (Arlington Heights, IL). Enhanced chemiluminescence (ECL) western blotting
detection reagents were purchased from Amersham Corp (Piscataway, NJ). SuperFect
Transfection Reagent was purchased from Qiagen (Valencia, CA). Luciferase Assay
System and p-galactosidase Enzyme System were from Promega (Madison, WI). All
other reagents were purchased from Sigma unless otherwise described.

3.2 Ceil Culture
RAW264.7 cells (murine macrophage-like cell line, ATCC TIB-71) were
cultured in LPS-free Dulbecco’s modified Eagle’s medium containing 10% (v/v) heatinactivated fetal bovine serum (FBS, Intergen) and 10 units/ml penicillin and 100 pg/ml
streptomycin (Life Technologies, Inc.) at 37 °C in 5 % CO 2 air environment. Human
embryonic kidney cells (293T cells) were provided by Sam Lee (Beth Israel Hospital,
Boston, MA) and cultured in the same medium used for RAW264.7 cells. Mouse
fibroblast cells, NIH3T3, was purchased from ATCC and cultivated in DMEM
containing FBS and penicillin/streptomycin as mentioned above.
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3.3 DNA Constructs
Flag epitope (Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Ly) tagged murine Tlr4 cDNA
constructs [both wild type and mutant; pFlag-CM Vl-TLR4 (wt), pFlag-CM Vl-Tlr4
(P712H). respectively] were kindly provided by Bruce Beutler (Southwestern Medical
Center, Dallas, TX). These constructs lack DNA sequences for the first 20 amino acids
representing the signal peptide. The Tlr4 (P712H) mutant found originally in LPShyporesponsive mouse strain (C3H/HeJ) has a missense mutation at position 712 to
replace proline with histidine.
The Flag-Tlr4 constructs were subcloned into pcDNA3.1/zeo (-) vector
(Invitrogen) and the Flag epitope tag was replaced with the HA-tag sequence (Tyr-ProTyr-Asp-Val-Pro-Asp-Tyr-Ala) by PCR cloning as depicted in Fig. 1.12. The first PCR
reaction was performed with the primers, Xho-SS-FOR and SS-HA-REV. The second
PCR reaction was performed with the primers, Xho-SS-FOR and Not-HA-REV, using
the first PCR product as a template. The final PCR product was inserted in Xhol and
N otl sites of pcDNA3.1/zeo (-)-Flag-Tlr4 (wt) and pcDNA3.1/zeo (-)-Flag-Tlr4
(P712H) plasmids, resulting in pcDNA3.1/zeo (-)-HA-Tlr4 (wt) and pcDNA3.1/zeo (-)HA-Tlr4 (P712H) constructs, respectively. The primers used are as follows: Xho-SSFOR, GTTAAACTCGAGCCACCATGTCTGCACTTCTGATCC; SS-HA-REV,
AGCGT AGT CT GGG ACGTCGT ATGGGT AAGC AACT GC AGCTCC AAC AAG;
NOT-HA-REV. GGGATTCGCGGCCGCAGCGTAGTCTGGGACGTCGTATGGG.
To prepare the truncated Tlr4 constructs [Flag/HA epitope tagged-ATlr4 (wt) and ATlr4
(P712H)] lacking extracellular LRR domain, DNA sequences spanning the epitope tag
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plus N terminal 21 to 78 amino acids and transmembrane plus cytoplasmic region
(amino acid 629 to 835) were amplified by PCR using Flag/HA-Tlr4 (wt) and Flag/HATlr4 (P712H) plasmids, respectively, as templates. The primers used for the PCR
cloning are as follows: Xho-Tlr-F208, GTT AA ACT CGAGCC AGG AT GATGCCTCC
CTGGCTCC; TlrR441Bam, ACACCGGATCCTTCTGAAAAATTGGAGAAGCT
ATAGC for amplifying N terminal region, and BmTlrF2092, GAAGGGGATCCAA
GACAATCATCAGTGTGTCAGTG, and Tlr-REV, CTCAGAGGATCCCTCCTCAG
GTCCAAGTTGCCG, for the region spanning amino acid 629-835, respectively. The
PCR products were subcloned into X hol and BamHl sites in pcDNA3.1/zeo (-)
expression vector for Flag/HA-ATlr4 (wt) and Flag/HA-ATlr4 (P712H). The integrity
o f the sequences was confirmed by DNA sequencing. The expression o f each construct
was verified after transfection into 293T cells by immunoblot analysis using
monoclonal Flag antibody (M 2) (Sigma), monoclonal HA antibody (12CA5)
(Boehringer Mannheim), and polyclonal anti-Tlr4 immune serum. Polyclonal anti-Tlr4
antibodies were prepared at the Core Laboratory, Louisiana State University Medical
Center (New Orleans, LA) using a polypeptide containing 16 amino acids (NHi-CysTrp-Arg-Arg-Leu-Lys-Asn-Ala-Leu-Leu-Asp-Gly-Lys-AIa-Ser-Asn-COOH) located
near the carboxylic terminus of human Tlr4. Expression plasmids for the wild type
NFicB-inducing kinase (NIK), pRK-NIK (wt), and a dominant negative mutant NIK.
pRK-NIK (KA), were gifts from Mike Rothe (Tularik, South San Francisco, CA). Wild
type murine MyD88, [Flag-MyD88(wt)], dominant negative mutant [FlagMyD88(ADD)], and constitutively active mutant [Flag-MyD88 (AToll)] were kindly
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Fig. 1.12. Schematic illustration o f different murine Toll-like receptor 4 (Tlr4)
cDNA constructs used in these studies. Tlr4 (wt), HA or Flag-tagged full length wild
type murine Tlr4; ATIr4 (wt), truncated HA- or Flag-tagged wild type Tlr4 lacking
extracellular leucine rich repeat region (LRR) which is a constitutively active form of
Tlr4; Tlr4 (P712H), HA or Flag-tagged full length mutant Tlr4 with the missense
mutation (substitution o f proline with histidine) at position 712. This mutant is found in
LPS-hyporesponsive mouse strain (C3H/HeJ); ATlr4 (P712H), truncated mutant Tlr4
lacking the extracellular LRR. The non-LRR region (the region for amino acid 21 to
78) was depicted as a closed rectangular at N-terminus. Cloning strategy for these
constructs is described in Materials and Methods. TIR domain, Toll/IL-IR homology
domain.
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provided by Jurg Tschopp (University o f Lausanne, Switzerland) (70). The FlagMyD88 variant constructs were subcloned into pcDNA3 expression vector (Invitrogen).
Expression plasmids for wild type inhibitor kappa B, [pCMV4-IicBa(wt)], and a
dominant negative mutant, [pCMV4-Ii<Ba (AN)], were provided by Dean Ballard
(Vanderbilt University, Nashville, TN). 2xNF-KB-Luciferase reporter construct was a
gift from Frank Mercurio (Signal Pharmaceuticals, San Diego, CA). HSP70-Pgalactosidase reporter construct was from Robert Modlin (University o f California, Los
Angeles. CA) (106). Mouse COX-2 promoter (-3,200bp) luciferase reporter construct
was from David DeWitt (Michigan State University, East Lansing, MI). All DNA
constructs were prepared in large scale using EndoFree Plasmid Maxi kit (Qiagen) for
transfection.

3.4 Luciferase Reporter Gene Array
RAW264.7 cells were plated in six-well plates (5x 105 cells/well) and transfected
with total 5 pg o f DNA plasmids including HSP-70-p-gal plasmid as an internal control
using SuperFect transfect reagent (Qiagen) according to the manufacturer’s instruction.
Relative luciferase activity was determined by normalization with P-galactosidase
activity as described elsewhere (106).

3.5 Radioimmunoassay to Measure the Amount of PGE2
RAW264.7 cells were plated at 0.5 x 106 per well o f a 6-well plate one day before
transfection. Total 5 pg o f plasmid DNA was transfected by using SuperFect transfect
reagent (Qiagen) according to the manufacturer’s instructions. The cell culture media
were collected 48 hours later for measuring accumulated prostaglandin E2 that was
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produced by cyclooxygenase. Levels o f prostaglandin E 2 in cell supernatants were
determined by radioimmunoassay as an indication o f COX enzyme activity. The
aliquots o f harvested media were transferred into plastic scintillation vials in triplicate.
The volume was adjusted to 500 pi with PBS-gelatin (0.1%). A triplicate set of
standards was run with each assay. The tritiated PGEi (3H) was added to each vial
containing natural PGE 2 from sample, and rabbit antisera raised against PGE 2 was
added. The samples in vials were mixed thoroughly, covered with parafilm and
incubated at room temperature. After 2 hours, secondary antisera (anti-rabbit gamma
globulin) was added to precipitate the primary antisera, the vials were mixed again and
in turn, were incubated at 4 °C for 48 hours. The vials were then centrifuged at 6,500g
for 45 min, decanted quickly and the precipitate was dissolved by the addition of 0.05 N
NaOH. Scintillation cocktail (EcoLume™, ICN, Costa Mesa, CA) was added to each
vial, followed by vortexing. Radioactivity was determined by counting in a Beckman
LS6800 scintillation counter. The data were analyzed and PGEi levels were determined
by using the computer program based on the logit-transformation.

3.6 Immunoprecipitation and Immunoblot Analysis
293T cells (1.2 x I06 cells/well) were seeded in 60 mm culture dishes and
incubated for 24 hours. Cells were cotransfected with a total 5 pg o f HA-ATlr4 (wt) or
HA-ATlr4 (P712H) plasmid and Flag-MyD88 (wt) expression plasmids. After 48
hours, cells were washed with PBS (pH 7.5) and lysed for 30 min on ice in 0.5 ml o f
RIPA buffer [150 mM NaCl, 50 mM Tris-Cl (pH 7.5), 5 mM EDTA, 1% Nonidet P-40,
0.5% Na-deoxycholate, 1 mM NajVOa, 1 mM (4-(2-Aminoethyl) benzenesulfonyl
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fluoride hydrochloride, 10 fig/ml Aprotinin, 10 pg/m l leupeptin]. Cell lysates were
clarified by centrifugation at 4 °C for 15 min at 12,000 g. Cell lysates were incubated
with 1 pg o f HA antibody (12CA5) for 4 hours and 70 pi o f 50 % (v/v) protein Aagarose (Pierce) was added for overnight incubation at 4 °C with rocking. Immune
complexes were solubilized with Laemmli sample buffer (90) after three washings with
lysis buffer. The samples were fractionated by 12% SDS-polyacrylamide gel
electrophoresis and transferred to polyvinylidene difluoride membrane. The
membranes were blocked with PBS - 0.1% Tween 20 containing 5% nonfat dry milk
and blotted with the indicated antibodies. The reactive bands were visualized with the
enhanced chemiluminescence system (Amersham) as described in our previous studies
(22,24,175.195).

52

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

4. RESULTS
4.1 Inhibition of NF kB Resulted in The Suppression of LPSStimulated COX-2 Gene Expression in RAW 264.7 Cells
Wadleigh et al. suggested that N F k B is dispensable for COX-2 gene expression by
LSP stimulation in mouse macrophage cells, RAW264.7 (193). They measured murine
COX-2 promoter activity by using -7 0 0 bp promoter reporter construct which has one
N F k B element around -400 bp region. However their results contradicted our previous

report regarding the role o f N F k B in LPS-induced COX-2 expression in macrophages
(24). Thus, this study was aimed to determine whether LPS-induced expression o f
COX-2 is mediated through activation o f N F k B . In this study, it was investigated
whether or not the inhibition of LPS-induced activation o f N F k B leads to suppression
o f COX-2 expression. N F k B inducing kinase (NIK) specifically activates IKK leading
to IkBcx degradation and to N F k B activation. Therefore, cells were co-transfected with
the luciferase reporter plasmid for N F k B or COX-2 promoter (-3.2kb) and an
expression plasmid containing a dominant negative mutant of N F k B inducing kinase
(NIK) or IkBoi expression construct in order to specifically inhibit N F k B signaling
pathway. The results show that LPS-induced COX-2 expression is significantly
inhibited by co-transfection o f cells with a dominant negative mutant o f NIK or IkB ci
(Fig. 1.1 3). These results indicate that the activation o f N F k B is required for the full
expression o f COX-2 in LPS-stimulated RAW 264.7 cells.
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Fig. 1.13. Suppression o f LPS-induced activation of NF k B and COX-2 expression
by a dominant negative mutant of NIK or Ik Bgc. RAW 264.7 cells were co
transfected with 2 pg o f luciferase reporter plasmid for NFkB response element (A and
C) or COX-2 promoter (B and D), and 2 pg expression plasmid containing dominant
negative mutant o f NIK(KA) or IkBoc(AN) cDNA. 1 pg o f HSP70-p-gal construct was
also included as a internal control. pRK and pCMV4 are the empty vectors for NIK and
Ik B ci cDNA, respectively. Transfected cells were treated with LPS (20 ng/mi) for 24
hours. Luciferase activity was measured as described in Experimental Procedures.
Panels are representative data from more than three different analyses. Values are mean
± SEM (n=3). RLA, relative luciferase activity (Fig. continued).
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4.2 Activation of NF kB by NIK Leads to Expression of COX2, and This Expression Is Suppressed by A Dominant
Negative Mutant o f IkBgi in RAW 264.7 Cells
NF k B inducing kinase (NIK) is known to activate IKK which leads to NF k B after
Ik B oi degradation. To date, NF k B activation is the only known biochemical function o f

NIK. Therefore, if direct activation o f NF k B without involvement o f LPS leads to the
expression o f COX-2, this result would support that the activation o f NF k B alone is
sufficient for the expression o f COX-2. RAW264.7 cells were co-transfected with NIK
and COX-2 reporter gene constructs. The results show that direct activation o f NF k B
by transfection o f cells with the wild-type NIK plasmid leads to the expression o f COX2 (Fig. 1.14, lane 1).
Additionally, IkBoi is the direct target protein by NIK-activated IKK and the
degradation o f IkBoi releases a free N F k B leading to activation o f N F k B . Therefore, if
NIK-induced COX-2 gene expression is inhibited by IkB ci, it implies that N F k B
activation is required for COX-2 gene expression. As shown in Fig. 1.14, co
transfection o f cells with NIK (wt) and a dominant negative mutant o f IkBcc
significantly suppressed the NIK-induced COX-2 expression (Fig. 1.14, lane 2).
Together, these results indicate that the activation o f NF kB is sufficient and required for
the expression o f COX-2 in LPS-stimulated macrophages. These data are also opposite
to the recent report by Wadleigh et al. (193).
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Fig. 1.14. Activation of NF k B by NIK leads to expression o f COX-2, which is
significantly suppressed by a dominant negative mutant o f k B a . RAW 264.7 cells
were co-transfected with 2 pg o f luciferase reporter plasmid for NFkB (A) or COX-2
promoter (B), and 2 pg o f expression plasmids containing NIK (wt) and a dominant
negative mutant of IkBcx (AN), respectively. 1 pg o f HSP-p-gal construct was included
as a internal control. Panels are representative data from more than three different
analyses. Values are mean ± SEM (n=3).
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4.3 Extracellular Domain Truncated Tlr4 (ATlr4) Functions
As The Constitutively Active Form to Increase The
Endogenous COX Enzymatic Activity Measured by The
Amount of Accumulated PGE2
In Drosophila, it was shown that the deletion o f extracellular leucine-rich repeat
(LRR) domain elicits the gain o f function o f Toll gene product (197). In addition, the
gain o f function by the truncated toll proteins lacking the extra-cellular domain was
demonstrated in human Tlr4 (198). Based on the reports from Drosophila Toll and
human Tlr4, extracellular domain truncated mouse Tlr4 (ATlr4 wt) and Tlr4 (P712H)
[ATlr4 (P712H)] constructs were prepared as described in Materials and Methods.
Mouse macrophage cell line, RAW264.7 cells, were transiently transfected with these
Tlr4 constructs to demonstrate if ATlr4 elicits COX-2 enzymatic activity as a
constitutively active form. After 48 hours o f transfection, the culture media were
collected for radioimmunoassay to measure the amount o f accumulated PGEi that was
produced by COX. As shown in Fig. 1.15, ATlr4 transfection increased the endogenous
level o f PGEi. This result implies that ATlr4 functions as the constitutively active form
o f Tlr4 and induces COX enzymatic activity in the absence o f any other stimulation. In
contrary, ATlr4 (P712H) did not increase the level o f PGE 2, which means COX
enzymatic activity was not affected by ATlr4 (P712H). Only one amino acid
substitution within the cytoplasmic region o f the protein causes these opposite results.
Therefore, it is needed to investigate the biochemical mechanism to elucidate the
discrepancy.
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Fig. 1.15. ATIr4 transfection increased the endogenous cyclooxygenase (COX)
enzymatic activity measured by radioimmunoassay. RAW264.7 cells were
transfected with 5 pg o f each type o f Tlr4 expression construct as indicated. 48 hours
after transfection, the culture media were collected to measure the accumulated PGE 2
which was produced by endogenous COX enzymes by radioimmunoassay as described
in M aterials and Methods. Values for lane 3, ATlr4 (wt) transfection, are significantly
greater than those o f other lanes (p<0.01). pcD NA 3.1 is the empty vector for Tlr4
variants. Values are mean ± S.E. (n=3).
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4.4 Constitutively Active Tlr4 (ATlr4), But Not The
Truncated Mutant [ATIr4 (P712H)] o f Tlr4 (P7I2H) Which Is
Found in LPS-hyporesponsive Mouse Strain (C3H/HeJ),
Activates NF kB And Induces COX-2 Expression in RAW
264.7 Cells
To determine whether or not activation o f Tlr4 is sufficient to activate NF kB and to
induce the expression o f COX-2, cells were co-transfected with the truncated mouse
Tlr4 construct (ATIr4) lacking the leucine-rich repeat extracellular domain and NF k Bor COX-2-luciferase reporter gene construct. The results show that transfection o f cells
with the constitutively active ATlr4 leads to activation o f NF k B and COX-2 expression
without LPS stimulation (Fig. 1.16). However the same truncated ATlr4 (P712H) with
the missense mutation at position 712 is unable to activate NF k B and COX-2
expression. Full length Tlr4 and full length Tlr4 (P712H) do not elicit NF k B activation
and COX-2 reporter gene expression. These results indicate that the activation o f Tlr4
is sufficient to activate NF kB and to induce COX-2 expression in RAW 264.7 cells.

4.5 Constitutively Active ATlr4-induced Activation of N F k B
And COX-2 Expression Are Suppressed by Inhibition of
N F k B with A Dominant Negative Mutant of NIK or IkBoc in
RAW 264.7 Cells
From the above results, we suggested that the L PS-stimulated COX-2 gene
expression is mediated through NF kB activation and the activation o f NF k B is not only
sufficient, but required for LPS-induced COX-2 gene expression. In addition, the
activation o f Tlr4 itself by using ATlr4 causes the COX-2 gene expression.
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Fig. 1.16. Constitutively active truncated Tlr4 (ATIr4), but not the mutant ATIr4
(P712H), activates NF k B and COX-2 expression. RAW 264.7 cells were co
transfected with 2 pg o f luciferase reporter plasmid for NFkB (A) or COX-2 promoter
(B), and 2 pg expression plasmid containing Flag-Tlr4 (wt), Flag-Tlr4 (P712H), FlagATlr4 (wt), Flag-ATlr4 (P712H), or pcDNA 3.1. 1 pg o f HSP70-p-gal construct was
also included. pcDNA3.1 is the empty vector for Tlr4 variants. Panels are
representative data from more than three different analyses. Values are mean ± SEM
(n=3). RLA, relative luciferase activity.
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Then, it is needed to elucidate the signaling pathway by which the COX-2 is expressed
by ATM . To determine whether the ATlr4-induced expression o f COX-2 is mediated
through activation o f N F k B , we investigated whether A TM transfection activates N F k B
and in turn, the inhibition o f N F k B by a dominant negative mutant o f NIK or IkBci
results in suppression o f ATlr4-induced COX-2 expression. Because NIK and IkB ci are
specific upstream signaling molecules for activating N F k B , the specific inhibition by a
dominant negative form o f NIK or IkBoi can be clear evidence to support that ATM induced COX-2 gene expression is mediated through N F k B . Therefore, COX-2 or
N F k B reporter plasmid was co-transfected with Tlr4 construct and a dominant negative

mutant NIK (KA) or Ik B c i (AN) into RAW264.7 cells. The results showed that ATlr4
transfection activated N F k B as shown in Fig. 1. 17, A and C lane 2 and NIK (KA) or
IkB ci (AN) which are dominant negative forms o f NIK and Ik B ci significantly

suppressed the ATLR4-induced N F k B or COX-2 reporter gene expression (Fig. 1.17).
These results indicate that ATlr4-induced COX-2 expression is at least in part mediated
through N F k B and the activation o f N F k B is critical to induce COX-2 gene expression
not only Tlr4-induced, but LPS stimulated COX-2 gene expression.

4.6 The Truncated Mutant [ATlr4 (P712H)J of Tlr4 (P712H)
Inhibits LPS-induced Activation o f NFkB And COX-2
Expression in RAW 264.7 Cells
Based on genetic evidence to date, Tlr4 is considered involved in LPS-stimulated
signaling, although there are several reports that Tlr2 instead o f Tlr4 is the LPS
receptor. Thus, we need to establish whether Tlr4 is true LPS receptor. Meanwhile,
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Vogel et al. showed in vivo genetic evidence that the missense mutation at Lps locus in
LPS-hyporesponsive mice, C3H/HeJ, exerts a dominant negative effect on LPS
sensitivity (40), although no functional and biochemical data for the mechanism by
which this defect exerts its profound effect have been published to date. Thus, it is
necessary to establish whether activation o f Tlr4 confers LPS-responsiveness and how
the missense mutation of Tlr4 [Tlr4 (P712H)] causes the LPS-hyporesponsiveness.
Therefore it was determined whether expressions of the mutant Tlr4 (P712H)
found in C3H/HeJ mouse strain and its LRR domain truncated form, ATlr4 (P712H),
inhibit N F kB activation and COX-2 gene expression in the presence o f LPS treatment.
The results show that the full length Tlr4 (P712H) and the truncated mutant ATlr4
(P712H) inhibit LPS-induced activation o f NF k B and COX-2 gene expression
(Fig. 1.18. lane 2 and 4). However, the truncated wild type ATlr4 enhances LPSinduced activation of NF k B and COX-2 expression because it functions as a
constitutively active form (Fig. 1.18. lane 3). LPS-responsiveness is slightly enhanced
in cells transfected with the full length Tlr4 as compared with vector transfected cells
(Fig. 1.18. lane 1). These results suggest that the full-length Tlr4 (P712H) and ATlr4
(P712H) act as the dominant negative mutant while ATlr4 is much more effective as a
dominant negative form o f Tlr4. Together, these results indicate that the activation o f
Tlr4 confers LPS-responsiveness in RAW 264.7 cells. However, our results do not
permit us to rule out the possibility that other toll-like receptors also mediate LPSresponsiveness in RAW 264.7 cells.
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Fig. 1.17. ATlr4 (wt)-induced activation o f NF kB and COX-2 expression are
inhibited by a dominant negative mutant o f NIK (KA) or IicBa (AN). RAW 264.7
cells were co-transfected with 1.5 pg o f luciferase reporter plasmid for NFkB (A and C)
or COX-2 promoter (B and D) and 1.5 pg o f expression plasmid containing
constitutively active truncated Flag-ATlr4 (wt), truncated mutant Flag-ATlr4 (P712H),
dominant negative mutant of NIK (KA) or IkBoi (AN), or respective vector. 0.5 pg of
HSP70-P-gal was also included as a internal control. pRK is the empty vector for NIK
variants. Panels are representative data from more than three different analyses. Values
are mean ± SEM (n=3). RLA, relative luciferase activity (Fig. continued).
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Fig. 1.18. The truncated mutant ATlr4 (P712H) with a missense mutation at
position 712 inhibits LPS-induced activation o f NF kB and COX-2 expression.
RAW264.7 cells were co-transfected with 2 pg o f luciferase reporter plasmid for NF k B
(A) or COX-2 promoter (B), and 2 pg o f expression plasmid containing full length wild
type Flag-Tlr4 (wt), mutant Flag-Tlr4 (wt), truncated wild type Flag-ATlr4 (wt),
truncated mutant Flag-ATlr4 (P712H), or vector. 1 pg o f HSP70-P-gal was also
included as a internal control. Cells were treated with LPS (20 ng/ml) or vehicle for 24
hours. pcDNA3.1 is the empty vector for Tlr4 variants. Panels are representative data
from more than three different analyses. Values are mean ± SEM (n=3). RLA, relative
luciferase activity.
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4.7 The Adaptor Protein MyD88 Is Co-immunoprecipitated
with The Wild Type ATIr4 but Not with The Mutant ATIr4
(P712H) in 293T Cells
It remains unclear why the missense mutation at 712 residue in Tlr4 elicits the
LPS-hyporesponsiveness. Thus, we investigated why the missense mutation to replace
proline with histidine at position 712 o f Tlr4 results in loss o f function. In case o f IL-R1
signaling pathway, the C-terminal TIR domain of MyD88 interacts with the TIR
domain of cytoplasmic region o f IL-1R by IL-1 stimulation and in turn, the N-terminal
death domain o f MyD88 associates with the death domain o f IRAK to transmit the
ligand-induced signaling. Since Tlr4 signaling pathway shares the same signaling
molecules as the IL-R1 signaling pathway. MyD88 was the first candidate to elucidate
the signaling pathway by Tlr4 activation. Medzhitov et al. demonstrated that MyD88 is
an adaptor protein directly interacting with the cytoplasmic Toll/IL-IR homology (TIR)
domain of human Tlr4 (49), and considered as one o f the most upstream components o f
the human Tlr4-mediated signaling cascade. We find that proline at 712 lies within this
TIR domain o f murine Tlr4, which is critical for binding MyD88 adapter protein. Thus,
we determined whether the mutation at position 712 interferes with binding o f MyD88
to Tlr4 resulting in failure o f the signal transmission.
Human embryonic kidney cells (293T cells) were co-transfected with an epitope
(Flag) tagged MyD88 and HA-tagged wild type ATlr4 or the mutant ATIr4 (P7I2H )
expression constructs. When cell lysates from these cells were immunoprecipitated
with anti-HA antibody and immunoblotted using anti-Flag or Tlr4 antibodies, MyD88
was co-immunoprecipitated with the wild type HA-ATlr4 (Lane 1, Fig. 1.19), but not
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with the mutant HA-ATlr4 (P 7 12H) (Lane 2, Fig. 1.19). These results suggest that the
mutant Tlr4 (P712H) is unable to interact with MyD88 and, thus fails in transmitting the
signal to the downstream signaling molecules.

4.8 Constitutively Active Form o f The Adapter Protein
MyD88 Rescues Inability of The Dominant Negative Mutant
Tlr4 to Activate The Downstream Signaling Pathway in RAW
264.7 Cells
The adaptor molecule MyD88 is known to be an immediate downstream signaling
molecule interacting directly with the TIR domain o f TIr4 (49). Proline at 712 position
is located in this TIR domain. Therefore, it would be interesting to determine whether
substitution of this proline with histidine resulting from the missense mutation interferes
with binding o f MyD88 to the TIR domain o f Tlr4. If the failure o f the mutant TIr4 to
activate downstream signaling pathways is due to its inability to recruit the adapter
molecule MyD88, transfecting cells with a constitutively active form o f MyD88 should
restore signal transmission. Indeed, co-transfection o f RAW 264.7 cells with the
dominant negative mutant [ATlr4 (P712H)] and a constitutively active form o f MyD88
lacking Toll/IL-IR domain [MyD88 (A Toll)] results in restoration o f N F k B activation
and COX-2 expression (Fig. 1.20). Taken together these results suggest that
hyporesponsiveness o f the mouse strain (C3H/HeJ) to LPS is due to the disruption o f
Tlr4-mediated signaling pathways resulting from inability o f the mutant [Tlr4 (P712H)]
to recruit the downstream signaling molecule MyD88.
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Fig.1.19. The adapter protein MyD88 is co-immunoprecipitated with the
truncated wild type ATIr4 (WT), but not with the mutant ATIr4 (P712H), in 293T
cells. The 293T cells were co-transfected with 2.5 pg o f expression plasmids
containing epitope-tagged full length murine Flag-MyD88 and 2.5 pg o f epitope-tagged
truncated wild type HA-ATlr4 (wt) cDNA, respectively, or the mutant HA-ATlr4
(P712H) cDNA. (A) Cell lysates were immunoprecipitated (IP) with monoclonal antiHA antibody and immunoblotted (IB) using monoclonal anti-Flag antibody. (B) The
membrane from panel A was reprobed with polyclonal Tlr4 antibodies, or (C) reprobed
with monoclonal anti-HA antibody. (D) The same cell lysates were directly
immunoblotted (IB) using monoclonal anti-Flag antibody. Failure to see a band in panel
A, lane 2 indicates that MyD88 does not interact with Tlr4 (P712H). pcDNA3.1 is the
empty vector for Tlr4 variants. Panels are representative pictures from three different
analyses.
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Fig. 1.20. The constitutively active form of the adapter protein MyD88 lacking
Toll/IL-IR homology domain |MyD88 (A Toll)] can override the dominant negative
effect o f the mutant ATIr4 (P712H). RAW 264.7 cells were co-transfected with 1.5
pg o f luciferase reporter plasmid for NFkB (A) or COX-2 promoter (B), and 1.5 pg o f
expression plasmids containing the truncated wild type Flag-ATlr4 (wt) or the truncated
mutant Flag-ATlr4 (P712H), and constitutively active MyD88 (AToll), or respective
vector. 0.5 pg o f HSP70-P-gal constructs was also included as an internal control.
pcDNA3 is the empty vector for MyD88 variants. Panels are representative data from
more than three different analyses. Values are mean ± SEM (n=3). RLA, relative
luciferase activity.
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5. SUM M ARY AND DISCUSSION
In this study, three important issues were presented concerning LPS-induced
signaling pathways in the murine macrophage cell line, RAW264.7. First, it was
established that the activation o f NFkB is sufficient and required for LPS-induced
COX-2 gene expression. These results contradict the results reported by Hershman's
group who suggested that the CRE and the NF-IL6 cis acting elements in the murine
COX-2 promoter are important for efficient COX-2 transcriptional induction by LPS in
murine macrophages, RAW264.7. They further suggested that the putative NFkB site
may not be required for the full-expression o f COX-2 in LPS-stimulated macrophages
(193). However, requirement o f NFkB has been demonstrated in another study using
pharmacological inhibitors o f IkBci degradation or nuclear translocation o f NFkB (24).
It is not clear what causes this discrepancy. The murine COX-2 luciferase construct in
this study contains 3.2 kb upstream promoter sequences, whereas, the COX-2 construct
used in another study showing the results different from ours contains only 700 bp
upstream promoter sequences (193). Although the kB binding site in murine COX-2
promoter is located within -400 kb, it is possible that other enhancer elements located
further upstream o f the 5' flanking region o f the COX-2 gene are required for the full
expression of COX-2 in LPS-stimulated RAW 264.7 cells. Indeed, two NFkB binding
elements have been found at —400 bp and -1525 bp in mouse COX-2 promoter region
and -261 and -5 5 5 bp in the human COX-2 promoter sequence, as described in Fig. 1.9
and Fig. 1.10. According to the results from Hershman’s group, they used -700 bp o f
murine COX-2 promoter reporter construct which contains only one NFkB element
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around —400 bp and suggested that NFkB is dispensable for LPS-induced COX-2 gene
expression. However, in this study, we used -3.2 kb o f murine COX-2 promoter which
contains both two known NFkB elements and any other cis acting elements.
Additionally, there may be more putative NFkB elements in the longer 5 '-flanking
region o f COX-2. Although Hershman's group suggested that NFkB element is not
required for COX-2 gene expression by LPS stimulation, contrarily, our results showed
that NFkB is required for LPS-induced COX-2 gene expression and sufficient for COX2 gene expression in RAW264.7 cells. Probably, more than two NFkB elements may
need to harmoniously work together to induce COX-2 gene expression, because they
used -700 bp COX-2 promoter containing only one NFkB element but our -3.2 kb
COX-2 promoter include two NFkB elements or more putative elements.
While the results in this study support that a requirement o f the activation o f
NFkB is critical for LPS-induced COX-2 gene expression in RAW264.7 cells, the cis
acting elements which play a role in the modulation o f COX-2 gene expression may
depend on the type of cell and stimulant. For example, Yang et al suggested that the
NF-1 element around -4 0 0 bp in the human COX-2 promoter region is a response
region for TGF-P induced COX-2 gene expression (199).
Second, it was identified whether or not the activation of Tlr4 confers LPS
responsiveness as evaluated by the activation o f N F k B and the expression o f COX-2.
Although it was not clear how the signaling pathway is transduced by LPS stimulation
due to the lack o f transmembrane domain in GPI-linked membrane bound protein,
CD14, until recently, CD14 was considered as the receptor for LPS. However,
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Beutlers’s group identified the mutation o f Tlr4 gene in LPS-hyporesponsive mice and
these results imply that Tlr4 is involved in LPS signaling as a receptor molecule on cell
surface. Meanwhile, Kirschning et al. suggested that human Tlr2, when cotransfected
with CD14 into 293 cells, conferred LPS-inducibility o f NF k B (61). However,
overexpression of human Tlr4 constitutively activated the NF kB reporter gene and
treatment of these cells with LPS did not enhance the reporter gene activity. Therefore,
it was so controversial that it needs to be established whether or not Tlr4 is the LPS
receptor.
The results from this study show that the transfection o f RAW264.7 cells with the
truncated ATlr4 as a constitutively active form o f Tlr4 elicits LPS-responsiveness
through NF k B activation, measured by the activation o f NF k B and the expression o f the
COX-2 promoter reporter construct (Fig. 1.15). Additionally, a constitutively active
form o f Tlr4 also increased the enzymatic activity o f the accumulated cyclooxygenases
in RAW264.7 cells (Fig. 1.16). Moreover, the results in this study showed that the
presence of a full-length o f Tlr4 (P712H) or a ATlr4 (P712H) causes the attenuation o f
LPS-stimulated signaling, because both the full-length o f Tlr4 (P712H) and the ATlr4
(P712H) function as the dominant negative mutant form o f Tlr4. These results suggest
that Tlr4 mediates the LPS-induced signaling leading to NF k B activation and COX-2
gene expression. Arbour et al. also showed that the missense mutations (Asp299Gly
and Thr399Ile) in the extracellular domain o f human Tlr4 causes a blunted response to
LPS in humans (196). Together with the biochemical evidence and the genetic
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evidence as mentioned previously, clearly indicate that Tlr4, but not Tlr2, confers LPSstimulated responsiveness.
Meanwhile, it was not known why the missense mutation o f P712H in mouse Tlr4
and the deletion mutation o f the Tlr4 gene cause the LPS-hyporesponsive phenotype in
C3H/HeJ and C57BL/10ScCr mouse strain, respectively. The third issue indicates that
the failure in interaction o f an adaptor protein, MyD88, with Tlr4 (P712H) leads to the
disruption o f LPS-stimulated signal transduction and eventually results in
hyporesponsiveness to LPS. The cytoplasmic region o f Tlr4 is TIR domain which
interacts with a TIR domain o f any other protein. The point mutation at P712H o f Tlr4
is located in its cytoplasmic TIR domain. Therefore, such point mutation interferes
with TIR domain mediated interaction between Tlr4 and MyD88 proteins.
Furthermore, Xu et al. recently showed that the mutation o f P681H in Tlr2 which is
equivalent residue in Tlr4 disrupts signal transduction in response to stimulation by
gram-positive bacteria. They also showed that the P681H mutation in Tlr2 abolished
interactions between Tlr2 and MyD88 (296). These data may also imply that MyD88 is
the common immediate downstream adaptor molecule for other Tlr proteins, not
restricted for Tlr2 and Tlr4.
Through the various signaling pathways including MAPK. and N F k B activating
pathways, LPS induces a diverse array o f gene expression including inflammation
marker gene products that are involved in innate immune responses and pathogenesis of
gram negative septic shock. In this study, it was identified that Tlr4 works as a toll gate
for LPS-induced gene expression through the activation o f NF k B and other signaling
i
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pathways ant} these results indicate that MyD88 is one o f the immediate downstream
signaling components for Tlr4-induced signaling pathways. In addition, it was
demonstrated that the transcription factor NF kB is crucial in regulating LPS-stimulated
gene expression. Therefore, our results underscore the importance o f Tlr4-mediated
signaling pathways in LPS-induced gene expression.
While LPS induces the activation o f both NF kB and MAPKs including ERK1/2,
JNK, and p38, to date, it was demonstrated that NF kB and JNK are activated by Tlr4
which is a known LPS receptor. It was shown that the co-transfection o f Tlr4 and MD2 induced the activation o f ERKs, JNK, and p38 by LPS in HEK293 cells (92).
However, as previously mentioned, MyD88 is the only adaptor protein that links
transmembrane protein Tlr4 to the activation o f NF k B and JNK. It is necessary to
investigate the mechanism by which p38 and ERKs are activated upon LPS.
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PART 2
THE INVOLVEM ENT OF A SRC FAM ILY
PROTEIN, LYN, IN INDUCING COX-2
GENE EXPRESSION
1. REVIEW O F LITERATURE
1.1 Structure of The Src Family Protein
The Src family o f protein tyrosine kinases is a member o f a family o f non-receptor
tyrosine kinases and it consists o f nine related proteins (Src, Yes, Lyn, Fyn, Lck, Blk,
Fgr, Hck, and Yrk). The Src proteins are involved in cellular transformation and
intracellular signal transduction. Src family members share the conserved domains: Nterminal acylation domain (SH4), unique domain, SH3, SH2, kinase domain (SHI), and
C-terminal regulatory domain (Fig. 2.1).
The N-terminal acylation domain is responsible for targeting the Src proteins to
the inner leaflet o f the plasma membrane and is required for its own activation. Nterminal acylation of Src family protein is mediated through the co-translational
myristylation or the post-translational palmitylation. AH Src family members contain a
consensus sequence o f attachment o f myristate: Met-Gly-X-X-X-Ser/Thr (Fig. 2.2).
During translation, the initiator methionine residue is removed by methionine
aminopeptidase and myristate co-translationally links to the N-terminal glycine residue
via amide bond by the soluble enzyme N-myristyl transferase. Studies with pp60src and
p56lck have shown that myristylation o f Src-related proteins is required for membrane

76

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

association. Non-myristylated mutants do not bind efficiently to membrane and do not
mediate cell signaling. However it was suggested that myristylation alone is not
sufficient to stably anchor a protein to lipid bilayer and additional factors must therefore
function to enhance membrane association o f myristylated proteins (200).
Indeed. Silverman et al. has identified a m otif o f three alternating lysine residues
within the N-terminal sequences o f the Src family members that functions in
conjunction with myristate to promote membrane binding (Fig.2.2) (201, 202). The
cluster o f basic amino acids in the Src family proteins forms electrostatic interactions
with negatively charged phospholipids localized primarily to the inner leaflet o f the
membrane bilayer.
In addition, post-translational acylation o f cystein residue 3 and/or 5/6 o f p56lck
and p59fyn with the 16 carbon fatty acid palmitate has been demonstrated. The
concensus sequence for palmitylation is myr-Gly-Cys and 7 o f the 9 Src family
members contain this sequence (Fig. 2.2). Compared to amide-linked myristylation
which is stable and irreversible, palmitylation is linked by a dynamic, reversible
thioester bond and Camp et al. isolated palmityl thioesterases which break the thioester
bond between palmitate and cysteine (203,290). Therefore, it was suggested that such
reversible palmitylation may be regulated by any signaling events.
Membrane targeting is considered as one o f the cellular functions o f those Nterminal acylation o f Src family proteins and it is required for their activation (204).
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SH4: myristylated /palmitylated JV-terminus,
required for membrane localization.
U (unique domain): varies between Src family members.
SH3: protein interaction domain,, binds Proline-rich region
SH2: protein interaction domain, binds phosphorylated tyrosine residues,
binds C-terminal phosphorylated tyrosine residue.
SHI: kinase domain, required for enzymatic activity,
initial region of SHI interacts with its own SH3,
contains autophosphorylation site.
R (regulatory domain): phosphorylated C-terminal tyrosine residue
interacts with its own SH2 domain for repression o f Src kinase.
Fig. 2.1. Schematic structure o f SRC family proteins. SH. src homology; myr,
myristate; pal, palmitate
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Fig. 2.2, Comparing N-terminal acylation motifs o f the Src family proteins. A short
m otif (SH4) within the N-terminal unique region contains signals for myristylation and
palmitylation, as well as other conserved amino acids. All Src family members contain
a consensus sequence o f attachment o f myristate: Met-Gly-X-X-X-Ser/Thr. The
initiator methionine residue is removed by methionine aminopeptidase and myristate
co-translationally links to the N-terminal glycine residue during translation. The
positively charged amino acids, Lysine (K) and arginine (R), are depicted in bold
character and the negatively charged amino acid, aspartic acid (D), is circled. The
cluster o f basic amino acids in the Src family proteins forms electrostatic interactions
with negatively charged phospholipids localized primarily to the inner leaflet of the
bilayer. The concensus sequence for palmitylation is myr-Gly-Cys, and 7 o f the 9 Src
family members contain this sequence. N-terminal cysteine residues are indicated in a
rectangular.
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While the situation is probably more complex, it was suggested that palmitylation
increases the efficiency o f membrane binding from the study on G a protein which
contains a myristylation and a palmitylation at N-terminal Gly and Cys residues,
respectively, similar to Src family proteins (205). Furthermore, studies o f p56lck and
p59fyn indicate that palmitylation o f Src family members enhances interactions with
glycosyl phosphatidylinositol (GPI)-linked proteins and influences membrane
localization (206,207).
Downstream o f the acylation m otif lies a short (50-80 amino acids) sequence,
termed the unique domain, that varies highly among each Src family protein. Two
distinct Src homology regions (SH3 and SH2) are followed. These regions are protein
interaction domains. SH3 domain interacts with specific proline-rich sequences (208).
The SH2 domain in turn binds to phosphorylated tyrosine residues in the context o f
specific amino acid sequences (209). SHI kinase domain is responsible for enzymatic
activity, and mutations within the kinase domain inactivate Src proteins. In addition,
the major autophosphorylation site is also located in this kinase domain, and mutation
o f autophosphorylation sites leads to decreased kinase activity. Finally, near the end o f
the Src family proteins is a conserved tyrosine residue (e.g. tyrosine 527 in Src and
tyrosine 508 in Lyn), that is critical for the regulation o f the molecule. This tyrosine
provides one o f the key regulatory features for Src proteins and is a defining feature o f
the Src family kinases (210).
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1.2 Regulation of The Src Family Proteins
c-src is the normal cellular proto-oncogene o f v-src transforming gene. The study
of the v-src oncogene demonstrated the active comparison o f differences between the
two molecules: v-src is the C-terminal truncated version o f normal c-Src such that Cterminal tyrosine at 527 residue is deleted (211). Furthermore, the reports that either
dephosphorylation or mutation o f Y527 constitutively activates the c-Src kinase and
enables it to transform cells, implicates this residue is a key regulatory element (291293). Evidence suggests that the phosphorylated C-terminal tyrosine interacts
intramolecularly with Src's own SH2 domain, thereby inactivating the kinase, as
depicted in Fig. 2.3. It has been postulated that the SH2-Y527 interaction would either
distort or cover the kinase domain, leading to its inactivation in this 'closed
conformation'. The recent crystallographic studies shows that the kinase domain
remains exposed, even in the ‘closed conformation' when the SH2 domain binds
phosphoryorlyated C-terminal tyrosine, such as Y527 in Src. However, in addition to
this interaction, the SH3 domain exhibits a separate intramolecular contact with the
initial region o f the kinase domain. Thus, inactivation o f the kinase may result from
torsional constraint where the dual binding o f the SH2 and SH3 domains prevents free
movement within the kinase domain (212-214). Mutation o f either SH3 or SH2 frees
this constraint and probably leads to decreased stability o f the other inhibitory
interactions. Indeed, mutations in the SH2 domain also activate the c-Src kinase, as
would be expected by disrupting this intramolecular interaction (211). Therefore, both
the SH2 and SH3 domains contribute to the regulation o f the kinase via intramolecular
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Fig. 2.3. Activation of the Src family proteins. The phosphorylated C-terminal
tyrosine interacts intramolecularly with Src’s own SH2 domain, thereby inactivating the
kinase by distorting or covering the kinase domain, leading to “closed conformation’.
The SH3 domain exhibits a separate intramolecular contact with the initial region o f the
kinase domain. Thus, inactivation o f the kinase may result from torsional constraint
where the dual binding o f the SH2 and SH3 domains prevents free movement within the
kinase domain. Mutation o f either SH3 or SH2 frees this constraint and leads to
disrupting such intramolecular interaction. CSK is the cellular Src kinase.
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Fig.2.4. The Src family proteins are phosphorylated by CSK and
dephosphorylated by CD45. Phosphorylation o f C-terminal Tyrosine residue is
carried out by the cellular Src kinase (CSK). The receptor protein tyrosine phosphatase.
CD45, is a candidate to dephosphorylate the C-terminal tyrosine residue o f the Src
family proteins.
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interactions and disruption of these interactions may be a major mechanism for
activation of Src. Phosphorylation o f C-terminal Tyrosine residue is carried out by
another kinase, the cellular Src kinase (CSK), and the targeted deletion o f CSK in mice
causes constitutive activation o f the Src family kinase (Fig. 2.4) (215, 216). Despite
considerable efforts, there is still uncertainty as to which protein tyrosine phosphatase
(PTP) dephosphorylates the C-terminal tyrosine residue o f the Src family proteins. In
lymphocytes, the receptor protein tyrosine phosphatase, CD45, is a candidate for PTP
and it is believed that CD45 is required for activation o f Src family kinase. Absence o f
CD45 raises the steady-state level o f Lck C-terminal phosphorylation and decreases the
cellular response to stimulation through the antigen receptor (217,218).

1.3 Functions o f the Src family proteins
Until the past few years, hypotheses predicting the normal cellular functions of
Src were based on studies o f the biological effects of over-expressed, mutationallyactivated forms. In fibroblasts, activated mutants o f Src and its relatives are oncogenic,
and in some other cell types, the same mutants induce differentiation. These biological
effects are presumably the consequence o f constitutive, high-level activation of
signaling pathways, including various pathways involved in PI3 kinase, PLCy, SHPT2.
Ras, STATs, etc. Combined with the observations that endogenous Src is activated in
growth factor-stimulated cells, the biological effects o f activated Src led to the
suggestion that its normal role might be to regulate cell proliferation and differentiation
(219). Similarly, in various hematopoietic cell lines, Src relatives are activated in
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response to antigen stimulation, and activated mutants can lead to the same responses as
antigen stimulation, such as proliferation and cytokine production (220). However,
direct attempts to identify the normal functions o f Src family kinases, by blocking their
function in living cells and organisms, have been hampered by problems o f redundancy
and specificity. To date, disruptions o f the mouse Src, Fyn, Lck, Hck, Fgr, and Lyn
genes have been reported (221 -223). The most noticeable defect in Src' mice is
osteopetrosis. Src is required for the normal differentiation and response o f osteoclasts,
a type o f myeloid cell that absorbs bone. However, the biochemical explanation on
such osteopetrosis in Src' mice is not clear (224). In addition, Fyn' mice showed
alterations in the hippocampus. Two subregions o f the hippocampus, the granule cell
layer o f the dentate gyrus and the pyramidal cell layer o f the CA3 region, have 25%
more neurons than in wild type mice. Such phenotype could be due to reduced cell
death (225). Another Fyn' mouse strain shows neurological abnormality early in life:
the neonates fail to suckle. This may be due to a 40-50% decrease in myelination in the
brains o f Fyn-deficient mice. However, the molecular explanations for such defects
were not clear (226,227).
In a mutant Jurkat cell line, a lymphocyte cell line that lacks Lck failed to respond
to antigen receptor stimulation with a Ca2+ flux. But re-expression o f Lck in this cell
line restores signaling. This proves the requirement for Lck for a Ca2+ response to
antigen stimulation o f Jurkat cells (228). In addition to Lck, another Src family
proteins, Lyn, was suggested to be involved in the response to antigen receptor in B
cells. Lyn disrupted chicken B cell line, Lyn' DT40, have delayed and reduced Ca2+
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mobilization in response to antigen receptor stimulation (229). In these cells, it was
determined that both Lyn and another cytoplasmic kinase, Syk, associate with the
tyrosine phosphorylated B cell antigen receptor (230,231). The studies with Lyn', Syk',
and Csk' DT40 cells suggested a model: Lyn phosphorylates the antigen receptor to
provide a binding site for Syk and then phosphorylates and activates Syk. According to
those results, Csk' DT40 cells contain activated Lyn as expected, since Src family
proteins are negatively regulated by Csk. In turn, the active Lyn activated Syk,
indicating that activation of Lyn can cause activation o f Syk (232). Furthermore, it was
shown that in Lyn' DT40 cells, Syk tyrosine phosphorylation and activation in response
to antigen is greatly reduced (233), but Lyn can still be activated in Syk' DT40 cells
(234). Furthermore, since antigen-induced phosphorylation of She is decreased in both
Lyn' and Syk' cells, it could be suggested that She may be phosphorylated by Syk not
Lyn (235). Therefore, a model for the relationship between Csk, Lyn, Syk, and She
with respect to the antigen receptor was provided in DT40 chicken B cells: Csk
activated Lyn phosphorylates the antigen receptor, providing a binding site for Syk, and
then phosphorylates Syk, and Syk in turn, phosphorylates She.
A growing number o f extracellular agents that would stimulate Src family kinases
were identified. In fibroblasts, Src, Fyn, and Yes are activated by platelet derived
growth factor (PDGF), colony stimulating factor-1 (CSF1), epidermal growth factor
(EGF), and fibroblast growth factor (FGF). They associate with the PDGF and CSF1
receptors through their SH2 domain (236-241). Various G-protein coupled receptors
including those for thrombin, endothelin-1, and F-met-leu-phe, also activate Src family
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kinases (242-245). In addition, oxidative or radiation stress appears to induce
transcription via activation o f Src family members (246, 247). Increased intracellular
calcium may also stimulate Src proteins (248). In lymphocytes, Src relatives are
activated by interleukin 2 (249).
As described above, Src family proteins participate in the broad range of signaling
events and nine Src family proteins participate in various signaling pathways so that it
may be hard to identify the essential functions that cannot be bypassed by other
pathways. However, the challenge for the future will be to describe the full range o f
signaling pathways in which Src family kinases participate.
Among the cellular enzymes that are involved in signal transduction, the protein
tyrosine kinases (PTKs) appear to play key roles in the initiation o f various signaling
cascades. The PTKs can be divided into two broad groups based on their predicted
structures. One group, which possesses extracellular domains that generally bind
polypeptide hormones, is the receptor PTKs, such as the platelet-derived growth factor
receptor, the epidermal growth factor receptor, the nerve growth factor receptor, and the
insulin receptor (250,251). The second major group lacks extracellular sequences and
is considered as the nonreceptor PTKs, even though many members o f this group
appear to be noncovalently associated with some type o f cell surface ligand-binding
protein.
There appear to be at least eight distinct families o f nonreceptor PTKs. These
include the previously identified Src, Abl, and Tes/Fps families as well as the recently
described kinases exemplified by focal adhesion kinase (FAK) (251), cellular Src kinase
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(CSK) (215), Janus kinases (JAK1, JAK2, and TYK2) (252, 253), spleen tyrosine
kinase (SYK) (254), and the interleukin-2-inducible T cell kinase (ITK) (255).
Among the PTKs, the Src family is currently composed o f nine members: Src,
Yes, Fyn, Lyn, Lck, Hck, Fgr, Blk, and Yrk. The Src family protein has the
characteristic structure: N-terminal acylation region, ‘unique’ domain, SH3, SH2,
kinase domain, and C-terminal regulation domain. The sequences necessary for
myristylation and stable membrane association are located at the N-terminus o f the Src
family protein. The myristate is covalently bound by amide linkage to a common
glycine residue at position 2 (256) and the palmitate is posttranslationally linked to
another common cysteine residue at position 3 (206). The 50- to 80-amino acid
‘unique’ domain is adjacent to the acylation sequence. The amino acid sequence of
‘unique’ domain is variable between Src family members. Followed are the roughly 50
amino acids SH3 (Src homology 3) and approximately 100 amino acid SH2 domain.
These regions share identity with other non-receptor PTKs, as well as other classes of
cellular regulatory and structural proteins. A major focus o f research has highlighted a
role for SH3 domain-mediated interactions in the regulation o f signal transduction
events. The SH2 domains o f these signaling proteins bind tyrosine phosphorylated
polypeptides. Tyrosine phosphorylation acts as a switch to induce the binding o f SH2
domains, thereby mediating the formation of heteromeric protein complexes. The
formation o f these complexes is likely to control the activation o f signal transduction
pathways by tyrosine kinases (257,258). SH3 domains are small modules found in a
diverse array o f proteins. The presence o f an SH3 domain confers the ability to interact
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with specific proline-rich sequences in protein binding partners (210,219,259,260). The
majority o f the carboxyl-terminal half o f the Src proteins represents the catalytic
domain (this would be the SHI domain), which is the region o f highest Src family
sequence identity. The catalytic domain includes the ATP binding site centered around
a common lysine residue and the site o f enzyme tyrosine autophosphorylation. The last
15 to 17 amino acids are termed the regulatory domain because deletion o f these
sequences or site-specific mutation o f the terminal tyrosine to some other amino acid
significantly activates the enzymatic function o f Src PTKs (211). Biochemically, such
alterations are related to the dephosphorylation status o f the last tyrosine residue in the
enzyme. In inactive and wild type Src proteins, the last tyrosine residue is
phosphorylated by another cellular PTK, C-terminal Src kinase (CSK). and the
phosphorylated carboxyl-terminal portion o f the enzyme interacts with the enzyme’s
own SH2 domain, thereby resulting in conformational change to hide the catalytic
domain and keeping Src inactive. However, such alterations in C-terminal regulatory
domain o f Src proteins result in exposing the catalytic domain to be activated.
Therefore, such alterations render Src PTKs constitutively active, and when expressed
in an appropriate cell type, these mutants are highly oncogenic. Meanwhile, in order to
activate a wild-type Src protein, the last C-terminal phosphorylated tyrosine should be
dephosphorylated by a cellular phosphatase. It is believed that the phosphatase CD45 is
a candidate to activate Src family kinases in T ceils (261,262).
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2. INTRODUCTION
Lyn is a member o f the Src family of intracellular membrane-associated tyrosine
kinases (263). Alternative splicing at the 5’ end o f the lyn gene results in the expression
o f p53 and p56 isoforms o f the protein (264.268,269). Lyn is expressed mainly in
hematopoietic cells o f myeloid (macrophage, monocyte, and platelets) and B lymphoid
origin (270). It is involved in the transmission o f signals from a number o f receptors
such as the IL-2 receptor, SM-CSF receptor, high-affinity IgE receptor (FceR l), B-cell
antigen receptor, and thrombin receptor (271-278). Furthermore, Lyn has been
implicated in the phosphorylation o f a number o f signaling molecules, including
phosphoinositol-3 kinase (PI-3K), ras GTPase activating protein (GAP), phospholipase
C (PLC) yi and mitogen-activated protein (MAP) kinase (274,276,279,280).
Herbimycin A, an inhibitor o f protein tyrosine kinases, blocked the LPS-induced
protein tyrosine phosphory lations and LPS-induced biological response (17).
Novogrodsky et al showed that tyrosine kinase inhibitors o f the tyrophostin AG 126
family inhibited LPS-induced tyrosine phosphorylation of MAPK. and production of
TN Fa, and prevented septic shock in mice (174). In addition, Orlicek et al
demonstrated that the Src family kinase-selective inhibitor, PP1 (4-amino-5-(4methylphenyl)-7-(/-butyl)pyrazolo[3,4-</]pyrimidine), inhibits LPS- and IFN-y-induced
iNOS and TNF productions in the murine macrophage cell line RAW264.7 (176,177).
Chanmugam et al reported that the Src family tyrosine kinases, Hck, Lyn, and Fgr, were
the major tyrosine-phosphorylated proteins in LPS-stimulated macrophages and another
protein tyrosine kinase inhibitor, Radicicol, suppressed the LPS-induced COX-2 gene
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expression (175). Several publications suggest that three members o f the Src-family o f
protein tyrosine kinases, Hck, Fgr, and Lyn, are strong candidates for the primary signal
transducers o f LPS responses (178,281-285). Moreover, expression in macrophages o f
a constitutively active mutant o f Hck augments TNF-a production while antisense
oligonucleotides to Hck inhibit LPS-induced responses (142). Chronic exposure (24-48
hours) o f macrophages to LPS induces increased synthesis o f Hck and Lyn, which
correlates with the ability o f LPS to prime macrophages for respiratory burst (285).
While all three o f these kinases are rapidly activated after LSP treatment, it was shown
that a portion o f intracellular Lyn was co-immunoprecipitated with CD 14 (178). All o f
these observations suggest that protein tyrosine kinases, especially Hck, Fgr, and Lyn
play critical roles in LPS-initiated signaling pathways. However, Lowell et al showed
by using hck_/' fgr‘/_ lyn'Atriple mutant mice that Hck, Fgr, and Lyn are not obligatory
for LPS-initiated signal transduction (185). Their analyses indicated that both elicited
peritoneal (PEMs) and bone marrow-derived macrophages (BMDMs) from the triple
mutant mice have no major defects in LPS-induced activation, although the total protein
phosphotyrosine level is greatly reduced in macrophages derived from the same mutant
mice. According to their studies, the activation of the ERJC1/2 and JNK kinases, as well
as the transcription factor N F k B. is the same in normal and mutant macrophages after
LPS stimulation, rhese data suggest that these Src-related kinases are not required for
LPS-induced macrophage activation, but do not exclude an important role for these
kinases in LPS-mediated signaling in normal macrophages. Other Src kinase family
protein may play a role in LPS-induced signaling events.
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The purpose o f this study was to determine whether or not Lyn participates in
LPS-induced signaling pathways leading to COX-2 gene expression that is induced by
LPS stimulation by using the conditional alleles for cytoplasmic Src-like tyrosine
kinases. Conditional alleles have proven essential for understanding the role o f many
genes because they add the dimension o f time to genetic analyses and thereby avoid the
myriad secondary effects and compensatory mechanisms brought into play when a gene
is constitutively absent or active. Recently, Schreiber’s group has developed a new
inducible expression system using the cell-permeable chemical inducer o f dimerization
(C1D) FK.1012 (266). FK1012 is a dimer of FK506 and induces dimerization between
two chimeric proteins containing the FK506-binding protein, FKBP (Fig.2.5). The
principle o f this inducible expression system is to activate a certain signaling molecule
by artificially inducing proximity with their effector targets. For the Src family kinases,
their ability requires membrane localization by an N-terminal acylation (204).
Additionally, all Src-family proteins have a conserved regulatory tyrosine residue at
their C-terminal end, which must be dephosphorylated for maximum activity as
previously described. For Lyn which is one o f the Src-family kinases, Tilbrook et al
already showed that a substitution o f 508 tyrosine residue with phenylalanine at the Cterminus o f Lyn (LynY508F) gives rise to a constitutively active Lyn protein. In
addition to a constitutively active Lyn (Y508F), the tyrosine residue 397 within the
kinase domain o f Lyn is critical for maintaining kinase activity. Thus, another
substitution o f the tyrosine 397 residue with phenylalanine [Lyn (Y397F)] also results
in a dominant negative mutant form o f Lyn (286). Therefore, our conditional allele has
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been designed to artificially localize a constitutively active Lyn chimera to the plasma
membrane. By regulating the membrane localization o f the active form o f Lyn, it is
possible to determine whether activation o f Lyn can induce COX-2 gene expression.
Besides a conditional allele, the tetracycline-controlled retroviral vector was used for
the transfection and the expression o f Lyn constructs (287, 288). The expression o f
endogenous COX-2 was then measured to determine whether or not the activation o f
Lyn can induce COX-2 gene expression and if the inhibition o f Lyn by Lyn (Y397F)
can suppress LPS-stimulated COX-2 gene expression.
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Fig. 2.5. The principle of the conditional allele: inducible activation o f Lyn protein.
A membrane-bound docking protein o f FKBP and a soluble targeting FKBP chimera
were co-transfected and the interaction between the expressed docking and targeting
proteins were induced by membrane permeable dimerizing agent, FK1012, which is a
dimer form o f FK506. FKBP is FK506 binding protein.
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3 . M A T E R IA L S A N D M E T H O D S
3.1 Lyn Expression Constructs for Conditional Allele
The original constructs for the conditional Lyn allele were kindly provided by Dr.
Schreiver in Harvard University, Cambridge, MA. pCMF2E expresses the membrane
docking protein and it expresses 2 tandem repeat o f FKBP (FK506 binding protein)
fused with membrane binding motif. Due to the membrane binding motif, the
expressed docking protein is localized to the cytoplasmic side o f plasma membrane. As
a targeting protein construct, human Lyn(Y508F) was modified to fuse 2 tandem repeat
of FKBP with soluble Lyn whose first 10 amino acids were removed by PCR cloning
with primers (Fig.2.6):
GCGGCACTAGTAGCTTGAGTGACGATGGAGTAGATTTG and
GGT AAGGATCCCT ATT ATGCGT AGTCTGGT ACGTCGT ACGG AT AAGGCTGCT
GCTGGAATTGCCCTTC. The PCR products was subcloned into Spel and BamHl
restriction sites o f pC FlE to produce pCFlE-2.\FKBP-(A10)Lyn(Y508F) which is a
soluble chimera o f FKBP and constitutively active Lyn. In addition, the PCR products
were inserted into the same restriction sites o f pCMF2E to produce pCMF2E-2xFKBP(A10)Lyn(Y508F) which has a membrane binding domain fused with FKBP and
constitutively active form o f Lyn. pCMF2E-2xFKBP-(A10)Lyn(Y508F) alone can be
localized to plasma membrane without docking protein, because it already contains
membrane targeting domain at N-terminal end.
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Fig. 2.6. The schematic representation of the cytosolic targeting protein, 2xFKBP(A10)Lyn(Y508F). C-terminal tyrosine was substituted with phenylalanine for the
constitutively active Lyn, Lyn (Y508F). N-terminal acylation motif containg 10 amino
acids was replaced with 2xFKBP in order to prevent a spontaneous membrane targeting,
but. FKBP m otif in Lyn (Y508F) chimera is able to interact with another FKBP in
membrane docking protein by the presence o f dimerizing agent, FK1012.
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Conversely, pCF 1E-2xFKBP-(A 10)Lyn(Y508F) does not contain the membrane
binding motif. It therefore needs a docking protein for membrane targeting. Therefore,
both of a membrane docking protein construct, pCMF2E, and a targeting protein
construct, pCFlE-2xFKBP-(A10)Lyn(Y508F). were co-transfected in to NIH3T3 cell
and the transfected cells were treated with dimerizing agent, FK.1012, to get a artificial
interaction between membrane bound 2xFKBP and cytosolic 2xFKBP(A10)Lyn(Y508F). Transfection o f these constructs into NIH3T3 cells was followed
the detail procedures as it was described in Materials and Methods in the previous
chapter.

3.2 Retroviral Expression Construct for Lyn
Mouse Lyn constructs including a wild type [Lyn(wt)], a dominant negative
mutant [Lyn(Y397F)], and a constitutively active mutant [Lyn(Y508F)] was provided
by Dr. Hibbs at the Ludwig institute in Melbourne, Australia (286). Flag epitope was
fused at C-terminal end o f each type o f Lyn by PCR with primers:
CC ATTGGT ACCG AAACTTCC ACC ACG AGCG AGAA ATATG.
TTTATCATCATCATCTTTATAATCCGGTTGCTGCTGATACTGC and
GTGCTTGCGGCCGCTATCATTTATCATATCATTTATCATCATCATCTTTATAA
TC. The PCR products were then subcloned into pcDNA3. l/zeo(-) expression vector.
Each cDNA construct was subcloned into the retroviral vector, pLinx (Fig. 2.7) (287).
The integrity o f DNA sequence was confirmed by sequencing the constructs.
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Fig. 2.7. The schematic representation of pLinx revtroviral vector. The genetic
organization of pLinx retroviral vector was from moloney murine leukemia virus
(MMLV). LTR, long terminal repeat; tTA, tetracycline-regulated transactivater; IRES,
internal ribosomal entry site; Neo, neomycin resistant gene; CMV, cytomegalovirus
enhancer-promoter.
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Fig. 2.8. The schematic procedure for transfection and infection with the retroviral
vetor, pLinx. The detail protocols were described in Materials and methods.
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3.3 Transfection and viral infection for stably transfected
colony
As described in Fig.2.8, “phoenix” cells (lx lO 6 cells) which are the packaging
cells were plated into a 60 mm dish one day before transfection. To prepare
DNA/Superfect reagent complexes, 5 pg o f DNA was diluted with serum free DMEM
incomplete media in an eppendorf tube. Superfect reagent (30pl) was added to the
same tube. The DNA/SuperFect reagent complexes were incubated for 10 minutes at
room temperature. Then, 1 ml o f complete media were added to the reaction tube. After
several pipettings, the complexes were added to the phoenix cells. After 3 hours
incubation, the media were removed and changed with DMEM complete media. After
24 hours post transfection, the culture media containing infectious viral particles
produced by transfected phoenix cells were transferred to 15 ml culture tube and
centrifuged at 1,500 rpm for 5 minutes at room temperature. Only the supernatant was
added to the target cells, NIH3T3 cells, for the infection. Four pg/ml o f Polybrene was
added to increase the efficiency o f infection. After 24 hours post-infection, the culture
media was removed and changed with complete media and 48 hour after transfection,
infected cells were harvested and plated with neomycin (800 ug/ml) containing media
for single colony selection in the presence o f 8 ug/ml if tetracycline. 1 or 2 weeks later,
single colony could be visible under a microscope and then, each colony was transferred
to the new culture dishes for propagation. Some o f the propagated single colony cells
were frozen for the aliquot and some o f the selected cells were prepared for a
cultivation with and without tetracycline to determine whether the expression o f stably
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transfected Lyn construct can be suppressed by the presence o f tetracycline and
induced by the absence o f tetracycline through western blotting.

3.4 Lyn Constructs
Wild type murine Lyn cDNA was provided by Dr. Margaret L. Hibbs in Ludwig
Institute for Cancer Research, Australia. Lyn (wt) cDNA was amplified by PCR with
primers FI and R1 and subcloned into N otl and BamHl sites o f p3xFlag-CMV14
expression vector (Sigma). Tyrosine at 508 residue was replaced with phenylalanine by
PCR with specific primers, F2 and R2, and EcoRl /Bam Hl fragment o f PCR product
replaced the C-terminal region o f Lyn (wt)-3xFlag to give rise to Lyn (Y508F)-3xFlag.
Although F2 primer contains a mutation at 397 residue as indicated below, subcloning
by EcoRl/Bam Hl sites result in only Y508F mutation because 397 residue is outside o f
the subcloning sites. Furthermore, the PCR product with primer F2 and R2 containing
Y397F mutation was also used as a mega-reverse primer with a forward primer, F I, for
PCR. The X bal/EcoR l fragment o f the PCR product was inserted into the same
restriction sites in Lyn (w t)-3\Flag to produce the Lyn (Y397F)-3xFlag construct. In
addition, X bal/EcoR l fragment from Lyn (Y397F)-3xFlag replaced the region in Lyn
(Y508F)-3xFlag to prepare Lyn (Y397F/Y508F)-3xFlag construct. A mutation o f C3A
in N-terminal region o f Lyn was achieved by PCR of Lyn (wt) with a specific forward
primer, F3, and R1. The PCR fragment containing C3A substitution was inserted into
N otl/X bal sites o f Lyn (wt)-3xFlag construct resulting in Lyn (C3A)-3x-Flag
construct. Additionally, Lyn (C3A)-3xFlag was used as a template for another PCR
with primers, F4 and R l, to prepare G2A/C3A mutations and the PCR product was
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inserted into N otl/X bal region o f Lyn (Y397F/Y508F)-3xFlag cDNA. Consequently,
it gives rise to Lyn (G2A/C3A/Y397F/Y508F)-3xFlag construct. The integrity o f the
complete DNA sequence was confirmed by sequencing all the constructs and the
expression o f Lyn constructs was verified by western blotting. All o f Lyn constructs
were described in Fig. 2.9 and the PCR primers for Lyn constructs were as follows: F I,
AAAGCGGCCGCACCCATGGGATGTATTAAATCAAAAAGG; R l, GATGAAA
GGATCCCGGTTGCTGCTGATACTGCCC; F2, CGAAGATAACGAGTTCACA
GCAAGGGAAGG (bold nucleotides stand for a mutated codon o f Y397F); R2, GAT
GAATGGATCCCGGTTGCTGCTGAAACTGCCC-3” (bold nucleotides stand for a
mutated codon of Y508F); F3, GAGAAAGCGGCCGCACCCATGGGAGCTATTAA
ATCAAAAAGG (bold nucleotides stand for a mutated codon o f C3A); F4, GAGAAA
GCGGCCGCACCCATGGCAGCTATTAAATCAAAAAGG-3 ’3' (bold nucleotides
stand for a mutated codon of G2A).

3.5 Luciferase Reporter Gene Array
RAW264.7 cells were plated in six-well plates (5 x l0 5 cells/well) and transfected
with total 5 pg o f DNA plasmids including HSP-70-P-gal plasmid as an internal control
using SuperFect transfect reagent (Qiagen) according to the manufacturer’s instruction.
Relative luciferase activity was determined by normalization with (3-galactosidase
activity as described in our previous study (106).
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Fig. 2.9. The schematic illustration of murine Lyn constructs. A kinase-defective
Lyn (Y397F) is a kinase-defective form o f Lyn due to a mutation o f Y397F within a
kinase domain o f Lyn protein. Lyn (Y508F) is a constitutively active form, because
Y508F in the regulatory domain leads to the open conformation o f Lyn protein. Lyn
(Y397F/Y508F) may also function as a kinase-defective form since it is still kinasedefective. The substitution o f Cys with Ala at 3 residue for palmitylation inhibits the
acylation at 3 residue in the protein. Gly at 2 is covalently linked with myristylate.
Therefore, the point mutation o f G2A blocks the myristylation o f Lyn protein.
Consequently. Lyn (G2A/C3A/Y397F/Y508F) is not available for the lipid-mediated
membrane localization by both myristylation and palmitylation and also kinasedefective protein with the open-conformation. Therefore, Lyn
(G2A/C3A/Y397F/Y508F) mutant may work as another inactive form o f Lyn.
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4. RESULTS
4.1 Conditional Allele of Lyn: Inducible Activation of Lyn
Both docking protein and targeting protein expression constructs for Lyn
conditional allele were co-transfected into NIH3T3 cells. The expression o f these
constructs was verified by western blotting protocol (Fig.2.10). Twenty four hours after
transfection, 1 pg/ml o f dimerizing agent, FK1012, was added to the cells for 1 day in
order to induce the interaction between the membrane bound docking protein and
cytosolic Lyn (Y508F). In turn, cell lysates were prepared in RJPA buffer for the
western blotting protocol with the COX-2 antibody to determine whether or not the
activation o f Lyn induces COX-2 gene expression. Although the docking protein and
the targeting protein were expressed, the treatment o f the dimerizing agent did not show
the expression o f COX-2.

4.2 Tetracycline-inducible Expression of Lyn Did Not Induce
COX-2 Gene Expression in NIH3T3 Cells
As described in Materials and Methods, tetracycline-inducible Lyn (Y508F), a
constitutively active mutant, was stably transfected into NIH3T3 cells. Each colony
whose Lyn expression is regulated by the presence o f tetracycline was isolated and its
inducible expression o f Lyn was verified by western blotting. As shown in Fig.2.11.
three colonies show the inducible expression o f Lyn (Y508F) by tetracycline. While
those colonies induce the expression o f a constitutively active Lyn [(Lyn (Y508F)], the
expression of COX-2 was not induced by the inducible expression o f Lyn (Y508F).
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Fig. 2.10. The expression of a membrane docking protein and a targeting protein
in NIH3T3 cells. The expression o f pCSFlE-(A10)Lyn (Y508F)-HA (cytosolic
targeting protein) and pCMF2E (membrane bound docking protein) was verified by
western blotting using Lyn antibody. pCMF2E-(AlO)Lyn (Y508F)-HA which has a
membrane binding domain at N-terminal o f the construct was also transfected. The
endogenous expressions of Lyn were also detected at the points o f 56 KDa and 53 KDa.
Lane 1, No DNA transfection; Lane 2, pCMF2E-(A10)Lyn(Y508F)-HA; Lane 3,
pCFlE-(A10)Lyn(Y508F)-HA (targeting protein); Lane 4, pCMF2E(docking protein).
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4.3 ATlr4(wt)- or LPS-induced COX-2 Promoter Activity Was
Suppressed by Herbimycin A in RAW264.7 Cells
It was already known that LPS responses could be suppressed by protein tyrosine
kinase inhibitor such as herbimycin A (Sigma). In this study, it was determined that
Tlr4 mediates LPS response leading to COX-2 gene expression. Therefore, ATlr4 (wt)induced COX-2 gene expression should be suppressed in the presence o f herbimycin A.
As shown in Fig.2.12, ATlr4 (wt)-induced COX-2 promoter activity was suppressed by
herbimycin A. This result may suggest that any protein tyrosine kinase, such as the Src
family protein, may participate in Tlr4-induced signal transduction pathways. Since the
chemical compound basically shows the unknown and nonspecific activity in addition
to its specific biochemical activity, it is not sufficient to establish the involvement o f the
protein tyrosine kinase in Tlr4 signaling pathways on the basis o f the result from
herbimycin A. Therefore, a study with a dominant negative mutant and a constitutively
active form o f the Src family protein, especially Lyn, is needed to determine whether or
not Lyn is involved in LPS- or Tlr4-induced signaling pathways.

4.4 Transfection of Lyn Variants Does Not Affect COX-2
Promoter Activity in RAW264.7 Cells
Several kinds o f Lyn variants were constructed as described in Fig.2.9. Lyn
(Y397F) is a kinase-defective mutant, because the mutated amino acid residue is in
kinase domain. Lyn (Y508F) is a constitutively active form, because a Y508F mutation
in C-terminal regulatory region results in a open conformation o f Lyn. Furthermore, the
acylation-defective Lyn mutants can not be localized to the cell membrane for its
activation. Therefore, these Lyn variants were co-transfected with COX-2 reporter
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construct into murine macrophage cell line, RAW264.7 ceils, to investigate whether or
not Lyn induces COX-2 gene expression. As shown in Fig. 2.13, any o f Lyn constructs
did not affect the expression o f COX-2 reporter construct. While both Y397F and
Y508F mutations were already verified as a kinase-defective and a constitutively active
mutation, respectively (286), in this study, Lyn (Y508F) did not affect COX-2 promoter
activity in RAW264.7 cells.
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Fig. 2.11. Tetracycline regulated Lyn (Y508F) expression in NIH3T3 cells. Lyn
(Y508F) construct in a retroviral vector was transfected and infected into NIH3T3 cells.
After selecting the stably transfected clones, each clone was screened to isolate the
tetracycline-regulated clones in which an expression o f the transfected Lyn (Y508F)
could be suppressed in the presence o f tetracycline and induced by the absence o f
tetracycline. Cell lysate from each clone with o r without tetracycline was used for
immunoblot assay with Lyn antibody as shown in the upper panel. The expression o f
Lyn (Y508F) was regulated by tetracycline in Clone #1, 6, and 7. Clone #6 showed
more efficient regulation o f Lyn (Y508F) expression. The same blot was stripped and
reprobed with COX antibody that recognizes the endogenous COX-1 and COX-2.
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Fig.2.12. Suppression o f ATIr4 (wt)- or LPS-induced COX-2 promoter activity by
herbimycin A in RAW264.7 cells. RAW264.7 cells were transfected with a luciferase
reporter plasmid for COX-2 promoter and a constitutively active form o f Tlr4, ATlr4
(wt), (Lane 1 and 2) or the empty vector for ATlr4 (wt) (lane 3, 4, and 5). The
transfected cells o f lane 3 and 4 were treated with LPS (20 ng/ml) for 20 hours. At the
same time, herbimycin A (0.5 ug/ml) (Sigma) was treated as indicated above and the
final concentration o f vehicle (DMSO) was 0.05%. Panels are representative data from
more than three different analyses. Values are mean ± SEM (n=3).
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Fig.2.13. Transfection o f Lyn variants does not affect COX-2 promoter activity in
RAW264.7 cells. RAW264.7 cells were co-transfected with 2 pg o f Lyn construct and
2 |j.g luciferase reporter plasmid for COX-2 promoter as indicated. 1 pg o f HSP70-P-gal
construct was also included as a internal control. A kinase-defective, Lyn (Y397F), and
a constitutively active form o f Lyn, Lyn (Y508F). (Lane 3 and 4. respectively) did not
affect COX-2 promoter activity. The empty vector transfected cells o f lane 8 were
treated with LPS (10 ng/ml) for 12 hours. Panels are representative data from more than
three different analyses. RLA, relative luciferase activity. Values are mean ± SEM
(n=3).
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5. SUM M ARY AND DISCUSSION
The conditional allele o f Lyn was designed to conditionally activate Lyn by
regulating the membrane localization o f Lyn protein. It is a good method to investigate
the biochemical function o f any membrane targeting protein, such as Src family protein.
Thus, the conditional allele o f Lyn was used to study its involvement in COX-2 gene
expression. The co-transfection o f a membrane docking protein and a Lyn targeting
protein did not induced the expression o f COX-2 in the presence o f dimerizing protein,
FK1026 (Fig. 2.10). However, it still need to be investigated under another modified
conditions, such as time course treatment or increased concentrations o f dimerizing
agent.
The tetracycline-regulated expression o f Lyn (Y508F) was shown in NIH3T3 cells
(Fig. 2.11). The inducible expression o f Lyn (Y508F) did not induce the expression o f
COX-2. Those results may imply that Lyn may not be involved in COX-2 gene
expression. However, Xie et al. showed that pp60v'src transfection induced COX-2 gene
expression by activation o f JNK in NIH3T3 cells (148). Furthermore, Yi et al. showed
that a constitutively active Hck [Hck (Y501F)] augmented TN Fa production in the
murine macrophage cell line, BAC1.2F5 cells (142). They also showed that inhibition
o f endogenous Hck expression with anti-sense oligonucleotides diminished LPSmediated TN Fa production in BAC1.2F5 cells. Together, these observations suggest
that a member o f the Src family o f tyrosine kinases is an important component o f the
signal transduction pathways leading to the pro-inflammatory cytokines. Indeed, a
protein tyrosine kinase inhibitor, herbymycin A, suppressed LPS- or ATlr4-induced
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COX-2 promoter activity in RAW265.7 cells, as shown in Fig. 2.12. Therefore, it may
require further investigation on whether or not activation o f Lyn is sufficient for COX-2
gene expression.
The Lyn variants including a kinase-defective and a constitutively active form
were constructed and co-transfected with COX-2 promoter reporter construct into
RAW264.7 cells. However, the transfection o f Lyn variants did not affect the COX-2
promoter activity as shown in Fig. 2.13. The constitutively active form o f Lyn, Lyn
(Y508F), did not induced the reporter activity, either. These results imply that Lyn may
not be involved in the signal transduction to COX-2 gene expression in RAW264.7
cells. The diminution o f COX-2 reporter activity by herbimycin A might be due to its
unknown specificity. Therefore, it is concluded that there may be no direct relevance
between Lyn and COX-2 gene expression in RAW264.7 cells.
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A PPEN D IX 1
YEAST-TW O HYBRID SYSTEM W ITH TLR4
Yeast-two hybrid protocol was performed by following DupLEX-A yeast twohybrid system (OriGene Technologies, Inc). The protocol involves fusing the E. coli
LexA protein with the cytoplasmic domain o f human Tlr4 as the bait construct and the
acid blob domain B42 with the human peripheral blood leukocyte cDNA library as the
target construct. The cytoplasmic domain o f human Tlr4 was subcloned into pEG202NLS vector for the bait construct using PCR cloning method with primers:
GCCGAGAATTCTCTGTTGTAGCAGTTCTGGTC and
CCATGGGATCCCTTCAGATAGATGTTGCTCTT. The binding sites for LexA is
placed upstream o f a reporter gene (such as lacZ) in order to monitor the transcriptional
activation by the interaction o f bait and target proteins. Thus, the yeast EGY48 reporter
strain was utilized for transformation with the bait and the target constructs and in turn,
the colonies with the activation o f reporter gene were selected for investigating the
identity of the target cDNA by DNA sequencing. By following the manufacturer’s
protocol, three positive clones were isolated and they are going to be identified by
further study.
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APPEN DIX 2
COM PONENTS FO R BUFFERS AND GELS

2 x Laemmli Buffer

125mM Tris-Cl (pH6.8), 20 % (v/v) glycerol, 5 % (w/v) SDS.
10 % (v/v) P-mercaptoethanol, 0.016 %(w/v) bromophenol blue.

RIPA B uffer

50mM Tris-Cl (pH7.4), 1% (v/v) Nonidet P-40, 0.25 % (w/v)
Sodium deoxycholate, 150mM NaCl, ImM EGTA. ImM
phenylmethylsulfonyl fluoride (PMSF), ImM Na 3VC>4 ,
10 pg/ml leupeptin, 10 pg/m l aprotinin.

Stripping Buffer

2% (w/v) SDS, 50mM Tris-Cl (pH6.8), lOOmM (pH 6.5)
P-mercaptoethanol.

TBS-T (pH7.6)

lOmM Tris-Cl, 150mM NaCl, 0.05% (v/v) Tween 20.

Transfer Buffer

lOmM NaHCOs, 3mM N aiC 0 3 , 20% (v/v) methanol(pH9.9)

Polyacrylamide gel

8 % Acrylamide/Bis solution, 400 mM Tris-HCl (pH 8.8),
10 % glycerol, 1 mM EDTA, 0.2 % SDS, 0.1 % APS
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APPENDIX 3
LIST O F ABBREVIATIONS

AA

Arachidonic Acid

AP-1

Activator protein-1

ATF2

Activating transcription factor 2

ATP

Adenosine triphosphate

CMV

Cytomegalovirus enhacer-promoter

COX-1

Cyclooxygenase-1

COX-2

Cyclooxygenase-2

CPLA2

cytosolic phospholipase A 2

CRE

Cyclic AMP response element

CSF1

Colony Stimulating factor 1

CSK

Cellular Src kinase

DD

Death domain

DHA

Docosahexaenoic acid

Dif

Dorsal-like immunity factor

DLAK

Drosophila LPS-activated kinase

DMEM

Dulbecco’s modified eagle's medium

DNA

Deoxyribonucleic acid

ECL

Enhanced chemiluminescence
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ECSIT

Evolutionarily-conserved signaling intermediate in Toll pathways

EDTA

Ethylenediaminetetraacetic acid

EGF

Epithermal growth factor

EPA

Eicosapentaenoic acid

ERKs

Extracellular signal-regulated kinases

FBS

Fetal bovine serum

FGF

Fibroblast Growth factor

FKBP

FK506 binding protein

GPI

Glycosyl phosphatidylinositol

HSP

Heat shock protein

IgG

Immunoglobulin G

Ik Bgc

Inhibitory kappa B alpha

IKK

Ik B kinase

IRES

Internal ribosomal entry site

IL-1

Interleukin-1

IL-1R

Interleukin-1 receptor

IL-lRAcP

Interleukin-1 receptor accessory protein

iNOS

Inducible nitric oxide synthase

IP

Immunoprec i pitation

IRAK

IL-lR-associated kinase
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JNK

c-Jun N-terminal kinase

JNKK

c-Jun N-terminal kinase kinase

KDO

3-deoxy-D-manno-octulosonic acid

LBP

LPS-Binding protein

LPS

Lipopolysaccharide

LRR

Leucine rich-repeat region

LT

Leukotriene

MAPKs

Mitogen-activated protein kinases

MAPKK

MAP kinase kinase

MAPKKK

MAP kinase kinase kinase

M EK -1

A synonym o f M APKK-1

MEK-2

A synonym o f MAPKK-2

NF- k B

Nuclear factor-kappa B

MyD88

Myeloid differentiation factor 88

NIK

NF-icB-inducing kinase

NSAIDs

Non-steroidal anti-inflammatory drugs

PBS

Phosphate-buffered saline

PDGF

Platelet derived growth factor

PGs

Prostaglandins

PGD 2

Prostaglandin D 2

PGE 2

Prostaglandin E 2

PGF 2

Prostaglandin F 2
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pgh2

Prostaglandin H2

PGHS

Prostaglandin H synthase

p g i2

Prostaglandin I2

PKC

Protein kinase C

PMA

Phorbol 12-myristate 13-acetate

PMSF

Phenylmethylsulfonicfluoride

PPARs

Peroxisome proliferator-activated receptors

PPRE

PPAR response element

PTKs

Protein Tyrosine kinases

PUFA

Polyunsaturated fatty acid

RIP

Receptor interacting protein

RXR

Retinoid X receptor

SAPKs

Stress-activated protein kinases

SDS

Sodium dodecyl sulfate

SH

Src homology

TF

Transcription factor

TIR

Toll/IL-IR homology domain

Tlr4

Toll-like receptor 4

TNFoc

Tumor necrosis factor alpha

Tollip

Toll-interacting protein

TRAFs

TNF-receptor associated factors

TRADD

TNF receptor associated death domain
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tTA

Tetracycline-regulated transactivater

TX A 2

Throm boxane A 2

U TR

3 ’-untranslated region
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